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ABSTRACT 
Ning Yu: Gingival Fibroblast and Epithelial Functions in Periodontal Disease- 
Modulation by Insulin Resistance 
(Under the direction of Steven Offenbacher) 
 
 
Periodontal disease is a biofilm-initiated inflammatory condition that affects the tooth 
supporting apparatus. Gingival epithelium provides an early line of defense against bacteria 
while gingival connective tissue fibroblast plays an integral role in tissue remodeling and host 
responses. Therefore, investigating the alterations of gingival fibroblast and epithelial functions 
in periodontal disease improves our understandings about the disease pathogenesis. In addition, 
both cells need energy support to survive and act, which comes from glucose utilization that is 
profoundly influenced by insulin response and glucose metabolism.  
In the second chapter, we find that acute gingival inflammation markedly induces insulin 
response genes. However, these changes are not evident in chronic inflammation. This study 
suggests that acute gingival inflammation may induce tissue metabolism, which may contribute 
to the pathogenesis of periodontal disease.  
In the third chapter, we demonstrate that advanced glycation end produts (AGEs) inhibit 
gingival fibroblast migration. In addition, lipopolysaccharides (LPS) potently induce PTGS2 and 
MMP1 genes transcription and prior exposures to AGEs enhance the up-regulation. LPS or 
AGEs fail to induce FGF2, which is an anabolic growth factor. This study links AGEs with 
accelerated periodontium destruction and impaired gingival wound healing during diabetic 
periodontitis.
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In the fourth chapter, we seek to unravel the role of desmosome structural molecule 
plakophilin-2 (PKP2) in periodontal disease. Decreased epithelial PKP2 is associated with 
periodontitis in gingival biopsy samples. Porphyromonas gingivalis (P.g) specifically degrade 
PKP2 protein through cysteine proteases, not serine proteases, or intracellular proteasomal or 
lysosomal degradation pathways. Although in vitro stimulations of P.g increase the overall PKP2 
DNA methylation level, periodontitis gingival biopsies do not display differential DNA 
methylation patterns compared to the healthy biopsies. Gingival epithelial cells that lack PKP2 
have inhibited cell proliferation, cell spreading, and impaired cell permeability. This chapter 
provides innovative evidence about the association between dampened desmosome molecules 
and periodontal disease. 
In summary, this dissertation work has deepened our knowledge about the pathogenesis of 
periodontal disease from both tissue and cellular levels. 
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CHPATER 1: INTRODUCTION 
Overview of gingiva 
Periodontal disease is a biofilm-initiated inflammatory condition that leads to destructions of 
periodontal tissue, which includes gingiva, cementum, periodontal ligament, and alveolar bone. 
In the oral cavity where over 700 species of microorganisms reside, the outermost layer of 
periodontal tissue-gingiva is exposed to constant microbial challenges (Hajishengallis, 2015). 
When dysbiosis occurs, the gingival-biofilm interface becomes disrupted which eventually leads 
to clinical symptoms of periodontal disease.  
Based on distinct anatomic characteristics, three types of gingiva are defined: marginal 
gingiva, attached gingiva, and interdental gingiva (Newman et al., 2012). Marginal gingiva is the 
free end of the gingiva, encompassing the teeth like a collar. It forms the soft tissue wall for the 
(Newman et al., 2012). Attached gingiva is the soft tissue area between marginal gingiva and 
alveolar mucosa. Cementum on the cervical side of the root and ridge of alveolar bones can be 
found underneath the attached gingiva. Attached gingiva also provides support for the gingival 
tissues to withstand mechanical forces during mastication, speaking, and tooth brushing 
(Newman et al., 2012). Interdental gingiva refers to the gingiva that fills the interdental space 
(Bath-Balogh et al., 2006). The shape and size of interdental gingiva depend on the contact area 
of the adjacent teeth. Losing interdental gingiva may cause esthetic failure, food retention, and 
potentially cause periodontal disease.  
Histologically, gingiva is composed of gingival epithelium and connective tissue. Gingival 
epithelium is characterized as stratified squamous epithelium, which from apical to basal side,
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has four layers of cornieum, granulosum, spinosum and basal (Newman et al., 2012). There are 
three distinctive types of gingival epithelium, namely sulcular epithelium, junctional epithelium, 
and oral epithelium (Hatakeyama et al., 2006). Sulcular epithelium lines the gingival sulcus and 
interacts with bacteria intensively. Junctional epithelium, being the base of the gingival sulcus, is 
responsible for gingival attachment to the teeth. During the progression of periodontal disease, 
junctional epithelium detaches from the tooth surface, which results in clinical attachment loss 
(Bosshardt and Lang, 2005). Both sulcular and junctional epithelium are non-keratinized 
epithelium. The keratinized oral epithelium is the outer layer of the gingival epithelium ranging 
from marginal to attached gingiva. The main function of gingival epithelium is to form a barrier 
to defend against mechanical, chemical and microbial intruders.  
 
Gingival epithelial functions 
Gingival epithelium provides an early line of defense against bacteria in the gingival sulcus 
during periodontal disease-associated bacterial disturbance (Schroeder and Listgarten, 1997). 
Most surfaces and cavities of human organs are lined with epithelium to act as physical and 
chemical barriers (Peterson and Artis, 2014). Therefore, much of our knowledge of epithelial 
functions is learned from organs like skin, intestine, urinary bladder, and eyes. An intact 
epithelial sheet relies on the three characteristics: 1) epithelial cell-to-cell adhesion; 2) epithelial 
homeostasis: 3) mucosal inflammation.  
Epithelial cell-to-cell adhesion  
No single human cell can survive without adhering and communicating with surrounding 
cells or extracellular matrix. Although cell-matrix adhesions play a crucial role in the host 
defense and disease progress, intercellular junctions are keystones for establishing lateral cell-to-
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cell adhesions. These junctional structures not only contribute to sealing the epithelium but also 
exert a variety of biological functions. Four types of intercellular junctions are commonly 
identified as tight junctions, adherens junctions, gap junctions, and desmosome junctions 
(Alberts, 2008).  In Figure 1.1-1.3, major components of intercellular junctions are presented 
(Durham and Garrett, 2009; Green and Gaudry, 2000; Neunlist et al., 2013) 
Tight junctions 
Tight junctions reside on the most apical side of the epithelium and have complex protein 
compositions. To date, at least 40 tight junctions-associated proteins have been discovered, but 
only three major transmembrane proteins are well characterized, which are claudin, occludin, 
and junctional adhesion molecule (JAM) (Gonzalez-Mariscal et al., 2003; Schneeberger and 
Lynch, 2004; Yamazaki et al., 2008).  
Occludin is the first identified transmembrane component of tight junctions with a 
transmembrane domain that passes through the membrane four times (Furuse et al., 1993). 
Within occludin, there are one N-terminus and one C-terminus facing inside and two 
extracellular loop domains facing outside of the cell. The long C-terminus functions as the 
docking sites for tight junctions-associated proteins (eg. ZO-1, ZO-2, ZO-3) (Furuse et al., 1994; 
Haskins et al., 1998; Itoh et al., 1999). Zonula occludens (ZO) are critical scaffolding proteins 
that bridge the transmembrane proteins and actin cytoskeletons. ZO also has a dual role in 
regulating cell growth (Bauer et al., 2010). Overexpression of occludin appears to increase 
numbers of tight junctions strands, with accordingly increased transepithelial electrical resistance 
(TER) activity, which is an indicator for tight junctions activities (McCarthy et al., 1996). 
Several lines of in vitro evidence have shown that disrupted occludin leads to impaired barrier 
functions (Bamforth et al., 1999). However, numerous studies have concluded that occludin is 
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not essential for tight junctions (Saitou et al., 2000; Schulzke et al., 2005). One piece of evidence 
is that occludin deficient mice are still viable and maintain an intact barrier in the GI tract as well 
as the urinary bladder. These findings have suggested that there might be alternative proteins for 
occludin (Schulzke et al., 2005). In endothelial cells from non-neuronal tissues, occludin is 
apparently missing even though the tight junctions complex persists (Hirase et al., 1997). 
Additionally, occludin-deficient embryonic stem cells bear proper tight junctions (Saitou et 
al., 1998). These findings have suggested that occludin mainly associates with tight junctions in 
a regulatory fashion (Nusrat et al., 2005). 
Claudin has a structure similar to that of occludin with a tetraspan transmembrane domain 
and a relatively shorter N-terminus and C-terminus facing cytosolically (Furuse et al., 1998; 
Morita et al., 1999). The C-terminus of claudin not only binds to ZO-1, ZO-2, ZO-3, but also 
binds to multi-PDZ domain protein 1 (MUPP1) and PALS-1 associated tight junctions protein 
(PATJ) (Jeansonne et al., 2003; Poliak et al., 2002). Since its discovery in 1998, claudin has 
become an integral transmembrane component of tight junctions (Furuse et al., 1998). When 
claudin is introduced into fibroblast that originally lacks tight junctions, fibroblast has newly 
formed tight junctions-like strands and starts aggregating. Claudin-1 deficient mice demonstrated 
a more severe phenotype than occludin deficient mice with much compromised epidermal 
barriers (Furuse et al., 2002). The interaction between ZO and claudin is also critical for tight 
junctions. A lack of ZO-1 significantly delays the assembly of tight junctions, suggesting that 
actin cytoskeletons are required to maintain the characteristics of tight junctions (McNeil et al., 
2006).  
JAM is another important transmembrane member of tight junctions. Unlike occludin and 
claudin, JAM has a single transmembrane domain and an intracellular C-terminus domain 
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containing PDZ binding motifs that bind to ZO-1 and MUPP-1 (Hamazaki et al., 2002). JAM 
participates in regulating epithelial barriers. One study showed that antibodies against JAM had 
no effect on changing the confluency of epithelial cells monolayers, but inhibited the 
reconstruction of tight junctions after being disrupted (Liu et al., 2000). Although inhibiting JAM 
in endothelial cells improves transendothelial migration of neutrophils, dampening JAM does not 
affect the transepithelial migration of neutrophils (Zemans et al., 2009).  
Adherens junctions 
Adherent junctions are positioned basally to tight junctions in epithelium and their molecular 
structures are relatively simple, comprising epithelial cadherin (E-cadherin), p120 catenin, β-
catenin, and α-catenin (van Roy and Berx, 2008). E-cadherin belongs to a family of cadherin 
proteins that are calcium-dependent. E-cadherin consists of an extracellular domain, a 
transmembrane domain, and a cytoplasmic domain. The extracellular domain forms bonds 
between adjacent cells, while the cytoplasmic tail binds to p120 catenin and β-catenin to exert 
biological functions (van Roy and Berx, 2008). Similar to other transmembrane proteins, E-
cadherin is assembled in the Golgi apparatus and later translocated to the plasma membrane. To 
engage in the dynamics of adherens junctions, membrane-bound E-cadherin experiences active 
turnovers through endocytosis and degradation (Bryant and Stow, 2004).  
p120 catenin binds to the juxtamembrane domain (JMD) of E-cadherin, which contributes to 
stabilizing adherens junctions complex at the cell membrane (Reynolds et al., 1992). No 
evidence supports that p120 participates in E-cadherin trafficking to the membrane, but p120 
prevents E-cadherin from endocytosis and degradation. This notion has been proved by many 
studies showing that loss of p120 promotes the transportation of E-cadherin to the lysosomes for 
proteolysis (Davis et al., 2003; Xiao et al., 2003). Therefore, it is not surprising to see p120 
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regulating E-cadherin expression (Ireton et al., 2002). Additionally, the interactions between 
p120 and microtubules assist in shifting roles of adherens junctions from cell adhesiveness to cell 
movement (Yanagisawa et al., 2004). β-catenin binds to E-cadherin as well, but only through the 
catenin-binding domain (CBD). Unlike p120, β-catenin is required for E-cadherin trafficking to 
the plasma membrane. The association between β-catenin and E-cadherin is essential for the 
transportation of E-cadherin from endoplasmic reticulum to the membrane, and protects E-
cadherin from being degraded. More importantly, β-catenin interacts with α-catenin, which 
subsequently couples with actin filaments and some other cytoskeleton-associated molecules, 
including vinculin, afadin, formin, and ZO-1 (Kobielak and Fuchs, 2004; Watabe-Uchida et al., 
1998). Theses interactions provide more pieces of evidence to prove that adherens junctions are 
closely associated with cell movement.  
In addition to its function as part of adherens junctions, β-catenin belongs to Wnt signaling, 
which controls many basic physiological processes like cell proliferation, cell polarity, and tissue 
homeostasis (Eastman and Grosschedl, 1999). When Wnt receptors are activated, β-catenin 
proteins start accumulating in the cytosol and translocating to the nucleus. Inside the nucleus, β-
catenin acts as a co-activator for the transcription factors family TCF/LEF, which controls the 
transcription of various target genes (Eastman and Grosschedl, 1999). In summary, adherens 
junctions play important roles in cell adhesion, cell motility, and linking the intercellular 
junctions to the intracellular signaling pathways.  
Gap junctions                                                                                                                                            
Gap junctions are formed by a cluster of connexin (Cx) proteins that contains a family of at 
least 21 members in humans (Naus and Laird, 2010). Six connexins aggregate to become a 
hemichannel-like connexon. Two connexons from the opposing cells contact and form a 
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channel-like structure of gap junctions. This organization creates a space (~2-4 nm) between the 
cells and this where the name of “Gap” is introduced (Maeda et al., 2009). Based on whether six 
connexins are from the same or different connexons, there are hetermeric or homomeric 
connexon channels. Connexins have distinct expression patterns among the cell or tissue types. 
For instance, Cx26 is highly expressed in the skin, cochlea, liver, and placenta, while Cx46 and 
Cx50 are predominantly found in retina cells. Moreover, Cx43 is considered to be the major gap 
junctions protein in cardiomyocytes (Evans and Martin, 2002). In gingival epithelium, Cx43 is 
abundantly expressed, while Cx32 is clearly missing and Cx26 is moderately expressed (Ye et 
al., 2000).  
Due to an unique architecture, gap junctions allow diffusions of ions (K+ and Ca2+), second 
messengers (cAMP, cGMP, and IP3), and small metabolites between cells, all of which 
participate in relaying electrical and biochemical signals across the body (Mese et al., 2007). In 
addition to the cellular communications, connexins bind with ZO-1, calmodulin, and tubulin to 
participate in cell movement (Barker et al., 2002; Giepmans et al., 2001; Peracchia et al., 2000). 
Cx43 is a functional target for Wnt signaling, which links gap junctions with adherens junctions 
(van der Heyden et al., 1998).  
Desmosome junctions 
Desmosome junctions are widely expressed at all layer of epithelium except for stratum 
cornieum (Getsios et al., 2004). Two cadherin proteins-desmoglein (DSG, 1-4) and desmocollin 
(DSC, 1-3) constitute for the extracellular components of desmosomes; three intracellular 
molecules-plakophilin (PKP, 1-3, and p0071-sometimes known as PKP4), plakoglobin (PG), and 
desmoplakin (DP) engage in bridging cadherin proteins to intermediate filaments (IF).  
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DSG and DSC are both glycoproteins that form strong adhesiveness between the opposing 
plasma membranes through their extracellular domains, in a calcium dependent manner. The 
interactions can be either homophilic (DSC-DSC, DSG-DSG) or heterophilic (DSG-DSC) 
(Chitaev and Troyanovsky, 1997; Syed et al., 2002). The role of DSG is widely studied in an 
autoimmune disease-pemphigus vulgaris (PV), which is caused by aberrant productions of 
immunoglobulins against DSG1 and DSG3 (Hashimoto et al., 1995). The phenotype of PV is 
characterized by basal keratinocytes dissociation in the epidermis and oral mucosa due to loss of 
desmosomes. Targeted disruptions of Dsg3 in mice led to the dissociations of basal cells in the 
oral mucosa, which mimicked the phenotype of PV (Koch et al., 1997). Functions of DSG1 are 
further described in bullous impetigo, in which exfoliative toxins secreted by Staphylococcus 
aureus specifically degrade DSG1, causing keratinocyte dissociations (Amagai et al., 2000). In 
addition to DSG, DSC1 is also a target in PV, as Dsc1 deficient mice display loss of cell-to-cell 
adhesions in the epidermis with defective barrier functions (Chidgey et al., 2001).  
Plakoglobin is also called γ-catenin due to its homology to the catenin members. Similar to β-
catenin, plakoglobin localizes with E-cadherin as well, but with much stronger binding affinities 
(Chitaev et al., 1996). Mice lacking plakoglobin have defective heart and skins as embryos 
(Bierkamp et al., 1996). Plakophilins are also important desmosome molecules, which will be 
discussed in a separate session. Desmoplakin is the most abundant desmosome molecule 
(Mueller and Franke, 1983). However, it does not bind to cadherins directly but rather bind to 
plakoglobin and plakophilin through its N-terminus binding sites. The C-terminus of 
desmoplakin directly binds to intermediate filaments. Mice lacking desmoplakin die in an early 
embryo stages with much compromised numbers of desmosomes (Gallicano et al., 1998). 
Although an epidermis-specific loss of desmoplakin in mice does not affect numbers of 
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desmsomes in the epidermis, desmoplakin-null keratinocytes have fewer desmosomes formed in 
vitro (Mueller and Franke, 1983). Actin organizations and sealing properties during the epithelial 
sheet formation are largely potentiated in Desmoplakin-null keratinoctyes (Mueller and Franke, 
1983). Therefore, ample evidence has suggested that desmoplakin is required for the assembly of 
functional desmosomes. In the absence of desmosome molecules, mice experience early embryo 
stalls due to malfunctions of the epidermis, neuroepithelium, heart and blood vessels, suggesting 
critical roles of desmosomes.  
In summary, intercellular junctions play crucial roles in cell-to-cell adhesion. Additionally, 
these molecules exert certain fundamental physiological activities. Much evidence has suggested 
that all four junctional complexes tend to work together by interacting with each other directly 
and indirectly.  
 
Epithelial homeostasis 
Epithelial homeostasis represents the basic biological features of epithelial cells, 
encompassing cell proliferation and differentiation, cell migration, and cell death/apoptosis.  
Epithelial cells are highly proliferative cells. Cell renewals usually occur at the basal layer 
where there is a niche for progenitor cells and stem cells to proliferate (Boers et al., 1998). 
Proliferative cells differentiate actively as they move to the apical side. During the proliferation 
and differentiation, cell polarity becomes crucial in deciding the asymmetrical distributions of 
molecules within different domains of the cell (Martin-Belmonte et al., 2001). There are two 
types of cell polarities: apical basalateral polarity and planar cell polarity. Apical basalateral 
polarity is used to describe the distinct distributions of organelles and molecules in the apical or 
basalateral plasma membranes. Epithelial sodium channels are most likely found at the apical 
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plasma membranes. In the lateral domain, junctional molecules are predominantly expressed. At 
the basal domain, integrin and hemidesmosome are uniquely expressed to adhere epithelium to 
ECM. The underlying control over the apical basalateral polarity has been widely studied with 
three complexes being identified: 1) PAR3-PAR6-aPKC complex; 2) Crumbs-PALS1-PATJ 
complex (CRB); 3) LGL-Scribble-DLG complex (Martin-Belmonte et al., 2001). Planar cell 
polarity refers to the polarization of cells within the plane of the cell sheet. When cells divide 
perpendicularly to the plane, it gives rise to stratified epithelium; when cells divide parallel to the 
plane, it expands the epithelial sheet (Rodriguez-Boulan and Macara, 2014).  
Cell migration is an integral part of epithelial homeostasis, playing a central role in tissue 
remodeling and disease development. Upon receiving biological or mechanical cues, cells spread 
on the attachment sheet and move to a designated area. Migratory activities largely rely on the 
cytoskeleton structures like actin, microtubules, and intermediate filaments. Both cell-to-cell and 
cell-to-ECM adhesions affect cell migration (Cuvelier et al., 2007; Vicente-Manzanares et al., 
2005). In a large-scale gene search, Simpson KJ et al has reported three major signaling nodes 
(β-catenin, β-integrin, actin) are involved in migration (Simpson et al., 2008). However, 
enhanced cell adhesion does not necessarily increase migration. In the same study, genes that 
accelerated migration may also inhibit adhesion, suggesting a negative correlation. In this end, 
cell adhesion and cell migration interact in two directions.   
Cell death refers to the cessation of cellular functions, which counteracts to cell proliferation. 
Highly proliferative epithelial cells require active cell death to maintain the epithelial 
homeostasis (Dannappel et al., 2014). There are three major types of cell death, which are 
necrosis, apoptosis, and autophagy (Kroemer et al., 2009). Many studies have demonstrated that 
pathogen components, bacterial metabolites, and inflammatory mediators promote gingival 
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epithelial cell death (Brozovic et al., 2006; Kang et al., 2012; Stathopoulou et al., 2009; Tsuda et 
al., 2010).  
 
Mucosal inflammation 
Although the role of epithelium in defending microorganisms has been empirically focused 
on its physical barrier capability, its immune aspects are also of great significance. Epithelial 
cells display several pattern recognition receptors (PRRs) that are either membrane-bound or 
cytoplasmic distributed (Peterson and Artis, 2014). Upon activations, PRRs promote a pyramid 
of signaling events to produce pro-inflammatory cytokines and chemokines. Pro-inflammatory 
cytokines like interleukin-1 beta (IL-1β), interleukin-6 (IL-6), and tumor necrosis factor alpha 
(TNF-α) promote inflammations to restrict infections. However, a prolonged inflammatory status 
brings damages to the tissue. Epithelial cells secrete a wide range of chemokines via PRRs to 
attract leukocytes to the local lesions to diminish bacterial or viral intrusions. Another immune 
feature for epithelial cells lies is to produce anti-microbial peptides, the expression of which also 
depends on PRRs (Nakatsuji and Gallo, 2012).  
For epithelial cells, two major PRRs are toll-like receptors (TLRs) and nucleotide-binding 
oligomerization domain (Nod) like receptors (NLRs) (Janeway and Medzhitov, 2002; Meylan et 
al., 2006). TLRs interact with bacterial components such as lipopolysaccharides (LPS), 
lipoproteins, flagellin, unmethylated CpG DNA, and etc. NLRs are cytoplasmic receptors that 
recognize bacterial peptidoglycan, bacterial toxins, and other pathogenic structures of 
microorganisms. NLR family pyrin domain containing 3 (NLRP3, also known as NALP3) 
contributes to IL-1β productions in gingival epithelial cells via activating the inflammasome 
(Bostanci et al., 2009; Yilmaz et al., 2010). Gingival epithelial cells that are challenged by P. 
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gingivalis produce high levels of IL-1β. Gingival epithelial cells that are challenged by A. 
actinomycetemcomitans induce high levels of IL-8 (Stathopoulou et al., 2010). F. nucleatum 
increase more IL-6 productions in gingival epithelial cells than commensal bacteria-S. gordini  
(Hasegawa et al., 2007). Via TLR2, P.gingivalis induce monocyte chemoattractant protein-1 
(MCP-1) and IL-8, both of which are chemokines that promote neutrophils to migrate and exert 
phagocytosis at the site of infections (Hasegawa et al., 2007).  
The best-characterized antimicrobial peptides in gingival epithelial cells are members of 
human β-defensins family (hBD). hBD-1 is constitutively expressed in gingival epithelial cells, 
while hBD-2 and hBD-3 are stimulation-dependent (Gursoy and Kononen, 2012; 
Krisanaprakornkit et al., 1998). hBDs are differentially regulated in gingival epithelial cells by 
oral bacteria regardless whether they are pathogenic or commensal (Gursoy and Kononen, 2012). 
Gingival epithelial cells markedly produce hBD in response to the challenge of F. nucleatum and 
TLR2 and NLRP2 are involved in this regulation (Ji et al., 2009).   
 
Overview of Plakophilins 
Plakophilins are a group of armadillo family members (PKP1, PKP2, PKP3, and p0071) that 
are widely expressed in many tissues and organs. PKPs are located in both cytosol and nucleus. 
In addition to being structural scaffolds to increase desmosome plaques, PKPs regulate the 
intracellular signalings as well (Bass-Zubek 2009).  
PKP1 is the first identified and smallest PKPs member (Heid et al., 1994). PKP1 expression 
is increased from basal to granular layers in stratified epithelium, suggesting its roles in 
keratinocyte differentiation (McMillan et al., 2003). PKP1 assists in forming desmosome 
junctions by recruiting partner desmosome molecules (eg. DSG1, DSC1 and DP) (Hatzfeld 2000, 
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Bornslaeger 2001). Patients with autosomal recessive defects of PKP1 gene have ectodermal 
dysplasia and skin fragility. In these patients, deregulated desmosome sizes and numbers can be 
found in the epidermis (McMillan JR, 2003).  
PKP2 is the best-characterized member of PKPs. Rare mutations of PKP2 gene in humans 
cause arrhythmogenic right ventricular cardiomyopathy (ARVC), which is an inherited heart 
disease that is characterized by a sudden myocardium breakdown (van Tintelen et al., 2006). 
PKP2 works in building cadherin-PKP-DP links in the desmosome assembly. A loss of PKP2 
results in failure of DP to accumulate at the cell border. Protein kinanse C alpha (PKCα) is the 
major functional molecule in this process. PKP2 recruits PKCα to form a complex with DP. 
Subsequently, PKCα phosphorylates DP, modulates its interactions with IF, and guides DP 
assembly into the cell border (Bass-Zubek et al., 2008).  Since PKP2 is the major PKPs member 
in cardiomyocytes, impaired PKP2 cannot be compensated by other PKPs, resulting in dampened 
desmosomes. Grossmann KS et al found that PKP2 null mice exhibited an embryonic lethality 
due to defects of heart morphogenesis, indicating PKP2 also plays important roles in cardiac 
development (Grossmann et al., 2004).  
Functions of PKP2 are not limited to being structural molecule of desmosomes. PKP2 is 
highly expressed in the basal layer of epithelium, an area that is particularly active for cell 
renewal. Studies have shown that PKP2 induces the phosphorylation of epidermal growth factor 
receptor (EGFR) to promote cell proliferation (Arimoto et al., 2014; Kazlauskas, 2014). 
Deficient PKP2 in keratinocytes leads to delayed migration through altered focal adhesion 
(Koetsier et al., 2014). An additional study has shown that PKP2 directly interacts with β-catenin 
to potentiate TCF/LEF1-mediated transcription of target genes (Chen et al., 2002). PKP2 also 
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associates with RNA polymerase III in the nucleus (Mertens et al., 2001). Since pol III regulates 
tRNA, rRNA 5S, and some small RNAs, PKP2 may present post-translational activities. 
Unlike PKP1 and 2, PKP3 is not expressed in the nucleus and mice lacking PKP3 present 
relatively mild phenotypes (Sklyarova et al., 2008). Current evidence associates PKP3 with 
cancer development. PKP3 binds to dynamin-like protein (DNM1L) to act in vesicle trafficking 
within the secretory pathway in non-small cell lung carcinomas (Furukawa et al., 2005).  By 
associating with RNA-binding proteins, PKP3 is involved in protein translation and RNA 
metabolisms responding to environmental stressors (Hofmann et al., 2006). p0071 is referred as 
PKP4 but its structure is more closed to p120 catenin. p0071 has been shown to regulate Rho 
signaling during cytokinesis (Wolf et al., 2006). In one study that shows the staining pattern for 
all PKP members in primary oropharyngeal tumors, only p0071 is associated with tumor grade, 
clinical parameters, and patient survivals (Papagerakis et al., 2003).  
It is noteworthy that even though PKPs have been described in various diseases, the role of 
PKP2 in periodontal disease remains unknown.  
 
Alterations of junctional molecules in periodontal disease  
Gingival epithelium is constantly exposed to microorganisms in the form of gingival plaque. 
To date, various studies have addressed the disturbance of junctional molecules under 
periodontitis and the underlying mechanisms.  
Gingival tissues contain many intercellular junctional proteins, which are listed in Table 1.1. 
The differences of junctional proteins between healthy and diseased gingival tissues are also 
documented. For instance, gingival biopsies from periodontal disease subjects have aberrant 
staining patterns for tight junctions proteins, including occludin, claudin-4 and 15, ZO-1 and 2, 
15 
and JAM-A (Choi et al., 2014; Ye et al., 2014). Fujita et al challenged rats with LPS in the 
gingival sulcus for 8 weeks and found that claudin-1 was significantly decreased in the junctional 
epithelium (Fujita et al., 2012). Numerous studies have also shown that E-cadherin is 
significantly reduced in periodontitis gingival biopsies than healthy controls (Arun et al., 2010; 
Loo et al., 2010; Nagarakanti et al., 2007). Connexin 26 and 43 are reduced in the pathological 
lining epithelium of periodontal pockets, indicating the alterations of gap junctions (Ye et al., 
2000). In addition, DSG1 and DSC1 mRNA are down-regulated in periodontitis gingival 
biopsies, indicating the alteration of desmosomes (Abe et al., 2011).  
While tissue data provides convincing evidence linking dampened junctional molecules to 
periodontitis, results from in vitro studies do not always have the same trend. Epithelial bound E-
cadherin can be degraded by P. gingivalis, which is mainly due to proteases produced by 
gingipain (Katz et al., 2000; Katz et al., 2002). However, cytolethal distending toxin (Cdt) from 
A. actinomycetemcomitans increases cytoplasmic distribution of E-cadherin and overall 
expression of β-catenin in both gingival tissue explants and gingival epithelial cells (Damek-
Poprawa et al., 2013). Proteases from P. gingivalis degrade occludin protein in epithelial cells, 
accompanied by decreased TER activities (Katz et al., 2002).  Collectively, bacterial products 
regulate junctional molecules productions, leading to altered epithelial homeostasis.   
 
Gingival fibroblast functions 
Human gingival fibroblast (HGF) is major resident cell in gingival connective tissue. One 
major function of HGF is to exert immune responses. This function is mainly through activations 
of PRRs. In addition to TLRs and NLRs, another important PRR in HGF is receptor for 
advanced glycation end products (RAGE) (Lalla et al., 2000). HGF potently produces pro-
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inflammatory cytokines (eg. IL-1 and IL-6), chemokines (eg. IL-8), and enzymes (eg. Cox-2, 
MMPs) under the circumstances of periodontitis or bacterial challenges (Morton and Dongari-
Bagtzoglou, 2001; Takada et al., 1991; Tamura et al., 1992; Yu et al., 2012). Although immune 
cells like monocytes and macrophages take a major responsibility in producing cytokines, both 
of them develop LPS tolerance quickly (Mages et al., 2007). LPS tolerance allows pathogens to 
escape from immune surveillance during sustained bacterial exposures and elongated 
inflammatory conditions. HGFs appear not to display LPS tolerance, which indicates that HGF 
may compensate for limiting bacterial effects when monocytes and macrophages are 
antisensitized (Ara et al., 2009).  
HGF is also responsible for synthesis and degradation of ECM, a group of molecules that 
constitutes for the backbones of the gingival architecture. HGF produces ECM and at the same 
time secrets matrix metalloproteases (MMPs) to degrade ECM. Therefore, HGF is the key cell in 
ECM remodeling within gingival tissues. Collagen is the major ECM in gingiva and the 
predominant type is type I collagen (Newman et al., 2012). HGF secrets a large amount of 
fibronectin as well, which is a glycoprotein that mediates the adhesions between fibroblast and 
ECM and fibroblast and surrounding cells. Over 20 MMPs have been identified in gingiva and 
many of them have distinct roles in development of periodontal disease: MMP1 and MMP8 are 
collagenases that degrade type I, II, III, and X collagens; MMP2 and MMP9 degrade gelatins and 
elastin; MMP3 and MMP10 degrade pro-collagen and fibronectin (Reynolds et al., 1994). 
Lastly, HGF engages in gingival wound healing processes (Hakkinen et al., 2000). Oral 
mucosa healing is scar free which is very distinct from skin healing. Because of this feature, 
many researchers believe that by investigating the uniqueness of oral mucosal healing, we may 
improve healings with scars as general (Mah et al., 2014). In some studies, gingival fibroblast 
17 
acquired from both mice and human gingiva demonstrates phenotypes of induced pluripotent 
stem (iPS) cells (Egusa et al., 2010; Wada et al., 2011).  
 
Alterations of gingival fibroblast in periodontal disease  
A good understanding about alterations of gingival fibroblast in periodontal disease sheds 
lights on the pathogenesis of periodontal disease. Whole or components of pathogens 
unanimously enhance productions of pro-inflammatory cytokines in HGF (Agarwal et al., 1995; 
Imatani et al., 2001). Topical additions of IL-1β and TNF-α result in increased transcription of 
IL-6, IL-11, and leukemia inhibitor factor (LIF) in HGF (Palmqvist et al., 2008). Both LPS and 
IL-1 induce prostaglandin E2 (PGE2) in HGF through increasing cyclooxygenase 2 (Cox-2) 
(Okamura et al., 1999; Richards and Rutherford, 1988). PGE2 is a well-known vasodilator 
engaging in increasing the vascular permeability and promoting inflammation that leads to 
periodontium destructions (Offenbacher et al., 1993).  
HGF presents altered ECM regulation during periodontal disease as well. Periodontitis 
connective tissues have decreased collagen fibers and MMPs when compared to healthy tissues 
(Seguier et al., 2001). Periodontal pathogens might be likely reasons since they make proteases 
that potently degrade ECM (Bachrach et al., 2004; Zhou and Windsor, 2006).  
Not many studies investigate the wound healing potential of gingival fibroblast under healthy 
or diseased conditions. Smoking has long been regarded as a risk factor for periodontitis and 
impaired wound healing.  Nicotine inhibits HGF migration via Rac signaling pathways (Fang Y 
2005).  
 
Glucose metabolism, insulin resistance, and periodontal disease 
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All human cells need to obtain energy in order to act and survive. Fat, protein, and glucose 
constitute for the major energy sources. Glucose uptake and utilization are predominantly 
affected by insulin. Glucose transporters (GLUT 1-4) and related insulin signaling molecules 
modulate glucose uptake. Inside cells, insulin regulates glucose utilization through a series of 
enzymatic reactions. Improper glucose metabolism leads to severe consequences and the most 
profound consequence is diabetes.  
Diabetes is a hyperglycemic condition that affects approximately 30 millions of Americans 
(Centers for Disease and Prevention, 2014). As the most common form of diabetes, type 2 
diabetes is characterized by insulin resistance, which refers to failures of tissues to react to a 
normal level of insulin. When unnecessary large amounts of glucose deposit in the tissues and 
organs, physiological damages occur with consequential complications. Periodontal disease is 
one of the diabetic complications and these two diseases share a two-way relationship (Mealey et 
al., 2006). Systemic inflammation is considered to be the common links between insulin 
resistance and periodontal disease. Major pro-inflammatory mediators are elevated in gingivitis 
and periodontitis subjects systematically (Page, 1991). A lot of these mediators are casually 
linked to altered glucose utilization and metabolism (Shoelson et al., 2006). TNF-α, IL-6, IL-1β, 
and increased level of oxidative stress are all known to cause insulin resistance by disrupting c-
Jun N-terminal Kinase (JNK) and insulin signaling pathways (Evans et al., 2005; Hotamisligil et 
al., 1993; Lee et al., 2003).  
Both GLUT1 and GLUT4 are expressed in gingival tissues, suggesting their potential roles in 
regulating glucose metabolism during periodontal disease development (Kuroki et al., 2009; Rao 
et al., 2012). The modulatory roles of inflammatory cytokines on glucose metabolism appear to 
be cell and tissue specific. TNF-α inhibits glucose uptake by decreasing GLUT4 expression in 
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the adipose tissue (Ruan et al., 2002). However, in noninsulin-sensitive tissues, TNF-α and IL-1β 
have been proved to increase glucose utilization (Shikhman et al., 2001; Yu et al., 1995). TNF-α 
is also known to block lipoprotein lipase production, which may as a result increase glucose 
utilization (Kim et al., 2001). Whether local gingival inflammation alters insulin response genes 
or glucose metabolism remains unknown. Therefore, we aimed to solve this puzzle in Chapter 2.  
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Table 1.1 Intercellular junctions proteins in human gingival tissue 
Types Proteins 
Tight junctions Claudin 1, 4, 15 
Occludin 
JAM-A 
ZO-1, 2, 3 
Adherens junctions E-cadherin 
β-catenin 
Gap junctions Connexin 26, 43 
Desmosome junctions DSG1, 2, 3 
DSC1 
  Desmoplakin 
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Figure 1.1 Major components of tight junctions and adherens junctions. 
 
Adapted from (Neunlist et al., 2013)  
 
 
 
22 
 
 
 
Figure 1.2 Gap junction components. 
 
Adapted from (Durham and Garrett, 2009) 
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Figure 1.3 Molecular structures of desmosome junctions. 
 
Adapted from (Green and Gaudry, 2000) 
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Abstract 
Background: Bacterial infections are known to alter glucose metabolism within tissues via 
mechanisms of inflammation. We conducted this study to examine whether insulin response 
genes are differentially expressed in gingival tissues comparing samples from experimental 
gingivitis and periodontitis subjects to those from healthy individuals.  
Methods: Total RNA was extracted from gingival biopsies from twenty-six participants 
including: 8 periodontally healthy, 9 experimental gingivitis, and 9 periodontitis subjects.. Gene 
expression patterns were evaluated using a PCR array panel to examine 84 candidate genes 
involved with glucose metabolism, insulin resistance, and obesity. Array data were evaluated 
using t-test adjusted by FDR (P<0.05) and Ingenuity Pathway Analysis (IPA) was performed for 
statistical testing of pathways. Although tissue samples were not sufficient to enable protein 
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quantification, we confirmed the up-regulation of the key gene using lipopolysaccharides (LPS) 
stimulated primary gingival epithelial cells by western-blot.  
Results: The mRNA expression patterns of genes that are associated with insulin response and 
glucose metabolism are markedly different in experimental gingivitis subjects compared to 
healthy controls. 32 genes are up-regulated significantly by at least 2-fold adjusted for FDR 
(P<0.05). Periodontitis subjects show similar but attenuated changes in gene expression patterns 
and no genes meet the significance criteria. IPA demonstrates significant activation of 
carbohydrate metabolism network in experimental gingivitis, but not in periodontitis. Glucose-6-
phosphate dehydrogenase (G6PD) protein increases in response to LPS stimulation in primary 
gingival epithelial cells, which is in the same direction as up-regulated mRNA in tissues. 
Conclusion: Acute gingival inflammation may be associated with tissue metabolism changes, 
but these changes are not evident in chronic inflammation. This study suggests that acute 
gingival inflammation may induce localized changes, which modify tissue insulin/glucose 
metabolism.  
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Introduction 
Periodontal disease is a biofilm-initiated inflammatory condition that affects the tooth 
supporting apparatus. Two major periodontal diseases, gingivitis and periodontitis respectively 
affect 75% and 47% of the adult population in the United States (Albandar et al., 1999; Eke et 
al., 2012). The pathogenesis of periodontal disease has been described in many aspects, but little 
is known regarding periodontal tissue glucose metabolism and insulin responsiveness.  
 Glucose is a major energy source for human cells besides fat and protein and inflammatory 
signals are likely to affect glucose metabolism. Insulin is critical for cellular uptake of glucose 
through the glucose transportation system and for activating enzymatic pathways of glucose 
metabolism to produce energy for cellular activation and survival. Within gingival tissues, the 
existence of major glucose transporters GLUT1 and GLUT4 is an indication that glucose 
metabolism may have a profound effect on periodontal tissue metabolism (Kuroki et al., 2009; 
Rao et al., 2012). Many studies have shown that certain pro-inflammatory cytokines that are 
elevated in gingivitis and periodontitis can modulate glucose utilization and metabolism (Page, 
1991; Shoelson et al., 2006). Tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), 
interleukin-1beta (IL-1β) and increased level of oxidative stress are all known to cause insulin 
resistance by disrupting molecular pathways including c-Jun N-terminal Kinase (JNK) and 
insulin signaling pathways (Evans et al., 2005; Hotamisligil et al., 1993; Lee et al., 2003). The 
modulatory roles of inflammatory cytokines on glucose metabolism appear to be cell and tissue 
specific. TNF-α inhibits glucose uptake by decreasing GLUT4 expression in adipose tissue 
(Ruan et al., 2002). However, in noninsulin-sensitive tissues TNF-α or IL-1β has been proved to 
increase glucose utilization (Shikhman et al., 2001; Yu et al., 1995). TNF-α is also known to 
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block lipoprotein lipase production, which may as a result increase glucose utilization (Kim et 
al., 2001). 
Gingivitis and periodontitis are both know to be associated with dramatic elevations in 
inflammatory cytokines and chemokines (Page, 1991). However, whether gingival inflammation, 
comparing acute and chronic gingival inflammation, affects glucose metabolism and insulin 
response gene expression locally is still unknown. Therefore, we conducted this study to begin to 
explore whether genes associated with glucose metabolism and insulin response were 
differentially expressed in gingival biopsies comparing experimental gingivitis and chronic 
periodontitis to healthy.  
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Material and Methods 
Study Participant Selection and Gingival Tissue Biopsies 
     Twenty-six participants, aged 18 to 64, provided informed consent and were recruited in the 
dental clinics from School of Dentistry at University of North Carolina at Chapel Hill. All 
procedures were approved by Institutional Review Board (IRB) of the University of North 
Carolina at Chapel Hill. Participants were sequentially enrolled with either periodontally healthy, 
experimental gingivitis or chronic periodontitis with the following exclusion criteria: 1. No use 
of antibiotics within one month before the screening examinations; 2. No signs of systemic 
diseases with any oral manifestation at the time of the enrollment; 3. No self-reporting treatment 
for systemic diseases three months prior to the collections of gingival biopsies. Besides obtaining 
demographic information and periodontal clinical parameters, examiners also recorded all 
participants’ weight and height to compute Body Mass Index (BMI).  
8 periodontally healthy participants were either healthy volunteers or patients who were 
undergoing crown-lengthening procedures and they exhibited ≤4mm probing depth (PD), no 
signs of bleeding on probing (BOP). 9 chronic periodontitis patients representing chronic 
inflammation were enrolled with exhibitions of ≥5mm of PD, presence of BOP and radiographic 
demonstration of bone loss. 9 experimental gingivitis patients representing acute inflammation 
were acquired from a 3-week stent-induced biofilm overgrowth procedure (Offenbacher et al., 
2009). A gingival biopsy was obtained from each subject at the site of marginal gingiva. 
Periodontitis gingival biopsies were acquired at the severely inflamed sites during a periodontal 
flap osseous surgery. For experimental gingivitis subjects, gingival biopsies were obtained at the 
end of 3 weeks of induction. Upon harvesting, all biopsies were immediately preserved in RNA-
later (Ambion) overnight at 4°C, and then transferred to −80°C for longer storage. 
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RNA Isolation and Assays for Insulin Response Genes Expression Profile 
Total RNA was isolated from gingival biopsies using RNeasy Mini kit (Qiagen). 600ng of 
the RNA were reverse transcribed to cDNA using RT2 First Strand Kits (Qiagen). To examine 
genes of interests, we used a diabetes-pathway focused RT2 Profiler PCR array (PAHS-023) in a 
7500 Sequence Detection System (ABI Prism, Applied Biosystems). The mRNA expression 
levels were normalized using Glyceraldehyde 3-phosphate dehydrogenase (GAPDH)  as the 
housekeeping gene. We performed the delta-delta Ct method to calculate fold-changes of 
regulated genes. The cut-off Ct value for qPCR was set at 35 and all genes within this threshold 
were included in the analysis. The identified genes were then mapped to known molecular 
networks in IPA to obtain statistical significance estimates for pathways and networks ranked by 
Fisher Exact scores.  
Cell culture, LPS stimulation, and Western blot 
Primary human gingival cells (HGEPs) were purchased from CellnTec and maintained 
according to the manufacture’s instructions. 1ug/ml Escherichia coli (E. coli, O55:B5) LPS 
(Sigma-Aldrich) was added to stimulate HGEP for 0, 4, 8, and 24 hours. Whole cell extracts 
were prepared by lysing the cells with ice-cold RIPA buffer (Cell signaling 10x buffer and 
Roche protease inhibitor mixture). The protein concentrations of the lysates were determined by 
DC protein assay (Bio-rad). The same amounts of protein were separated by 4-12% Bis-Tris gels 
and transferred to a nitrocellulose membrane (BD). The membrane was blocked 1h in 5% milk 
powder/TBST solution and then overnight blotted with anti-G6PD (H160, Santa Cruz) or anti-β 
actin antibodies (13E5, Cell signaling). Membranes were washed three times with TBST, and 
incubated with anti-rabbit HRP-labeled secondary antibody in TBST and developed using ECL 
system (SuperSignal West Pico; Pierce).  
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Statistical Analysis 
To compare gene expression in different groups, we used web-based RT2 profiler PCR 
array data analysis version 3.5 (http://pcrdataanalysis.sabiosciences.com/pcr/arrayanalysis. php). 
This web-based analysis by default employs the student t-test to examine the differences between 
groups, which increase type Ι error. To correct for this error, we applied false discover rate 
(FDR) test to calculate a stringent statistical significance and the significance level was set at 
0.05. To explore potential confounding effects of age on expression patterns, we used multiple 
linear regression models. For network analysis using IPA, the significance of the networks was 
calculated using the right-tailed Fisher Exact Test.  
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Results 
Participants 
 The demographic information and periodontal parameters of the participants are shown in 
Table 2.1. No statistically significant differences in age, gender, race, BMI, and smoking history 
were found among participants with either healthy or diseased gingival tissues. As expected, 
clinical parameters such as probing depth and attachment loss exhibited higher readings in 
chronic periodontitis subjects compared to healthy and gingivitis participants.  
Gene Expression Patterns in Gingivitis and Periodontitis Subjects.  
We compared gene expression patterns between healthy, experimental gingivitis, and 
periodontitis gingival biopsies. The volcano plot showing the log2 (fold change) plotted versus 
the –log10 (p value) for the 76 genes that were within the Ct value threshold can be seen in 
Figure 2.1. Genes that were up-regulated by at least 2-fold are illustrated in Figure 2.1 as red dots 
with the clustering of genes within the upper right quadrant for statistically significant genes. 
Only a few genes were down-regulated as indicated as green dots. In Figure 2.1A which 
compared gingivitis to healthy subjects, 45 genes were up-regulated >2-fold and 32 of them were 
at p<0.05 after FDR adjusted t-test. In this comparison, 5 genes were down-regulated >2-fold but 
none of them reached statistical significance (p>0.05). In Figure 2.1B, periodontitis group 
showed similar directional but much attenuated changes in gene expression with 15 genes being 
up-regulated >2-fold. None of them reached statistical significance by FDR. Only 1 gene was 
found down-regulated >2-fold but did not reach statistical significance as well (p>0.05). In Table 
2.2, we reported the complete expression data for each individual gene in gingivitis and 
periodontitis groups. To explore potential confounding effects of age on gene expression, we 
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chose the top 4 regulated genes in overall comparisons (G6PD, IFNG, CEBPA, DUSP4) and 
analyzed their fold regulation differences adjusted by age. In Table 2.3, age-adjusted fold change 
for these genes did not differ much from the unadjusted fold change. When comparing gingivitis 
to healthy subjects, the age-adjusted fold change differences were even slightly increased. For 
instance, adjusted G6PD fold regulation was increased by 11%. This gene expression profile 
suggests that genes that are associated with glucose metabolism and insulin responsiveness are 
more highly expressed in acute gingival inflammation, but not significantly up-regulated in 
chronic inflammation.  
Molecular Networks Analysis in Gingivitis and Periodontitis Subjects 
To further understand the molecular pathways associated with glucose metabolism and 
insulin responsiveness, we used IPA to analyze molecular networks. To include regulated genes 
that are more relevant in the network analysis, we used fold regulation at 1.5 as the cutoff 
threshold. Figure 2.2A shows the top 5 activated networks in gingivitis subjects comparing to 
their healthy counterparts. Each network is endowed with a score and in IPA score of 2 or higher 
suggests that networks have at least a 99% confidence of not being generated by random chance. 
Since we used the targeted array, the highest ranked network was endocrine system disorder, 
metabolic disease and carbohydrate metabolism (p=1x10-25). As delineated in Figure 2.2A, the 
majority of key molecules in this network were up-regulated (red nodes) by acute inflammation 
with only AKT2 and NFkB1 genes being down-regulated (green nodes). Figure 2.2B shows the 
top 4 activated networks in periodontitis subjects comparing to healthy controls. There are some 
shared functions within these networks, but more potent activations were observed in gingivitis 
subjects. It further proves that activation of glucose metabolism and insulin responsiveness was 
more potently induced by acute gingival inflammation.  
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G6PD protein expression increases in response to LPS stimulation 
To confirm that the elevated mRNA expression data seen in experimental gingivitis likely is 
mirrored by increased protein expression we created an in vitro acute inflammatory by 
stimulating HGEPs with E. coli LPS and detected G6PD protein expression by Western blot. 
G6PD was selected as a marker because it was the top up-regulate mRNA species identified 
(Table 2.2). As demonstrated in Figure 2.3, G6PD protein expression increased in response to 
LPS stimulation starting from 4 hours of stimulation, suggesting that inflammatory stimuli likely 
induce G6PD on both mRNA and protein levels. 
The Modulating Roles of Obesity  
To address the potential role of obesity in modulating insulin responses, we divided all 
three groups of subjects to obese and non-obese subgroups based on BMI. After normalizing 
against non-obese healthy subjects, fold change ratio of obese/non-obese diseases subjects are 
presented in Figure 2.4. It appears that majority of the fold change differences between obese 
and non-obese subjects are within 2-fold differences. In gingivitis group, more genes are 
regulated great than 2 fold (Figure 2.4A). Due to limited sample sizes, we focused more on trend 
instead of performing statistical analysis.  
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Discussion 
This study suggests that during the induction of experimental gingivitis, the acute gingival 
inflammatory response is locally activating glucose metabolism and insulin response genes, but 
in chronic inflammation there has been a re-establishment of a relative balance in insulin/glucose 
metabolism within the local gingival tissues.  
The experimental gingivitis group has an overall markedly up-regulated gene profile for 
these glucose/insulin response genes. As can be seen in Table 2, the top 4 up-regulated genes in 
gingivitis biopsies are G6PD, IFNG, CEBPA, and DUSP4. Both tissue mRNA data and gingival 
epithelial cells protein data suggest that gingival inflammation affects G6PD expression (Table 
2.2 and Figure 2.3). The augmentation in G6PD is likely a response to attenuate oxidative stress 
by generating NADPH, rather than participate in the pentose or carbohydrate driven pathway for 
5-carbon sugars. The increased INFG mRNA is a clear sign for inductions of gingival 
inflammation since interferon-γ is an activator for both innate and adaptive immunity. Wong N 
et al demonstrated that restricting interferon-γ in mice improved their glucose metabolism (Wong 
et al., 2011). There was also a significant increase in CEBPA, which encodes for CCAAT 
enhancer binding protein-α that controls transcriptions of GCSF and IL6R genes, therefore 
affects granulocytes differentiation (Zhang et al., 1998). LPS from P. gingivalis, IL-1β, IL-1α 
and TNF-α all enhance DNA binding activity of CEBPA in vitro, suggesting that CEBPA may 
be linked to periodontal inflammation (Kido et al., 2005). DUSP4 is a downstream transcription 
factor of MAPK pathway and it forms a negative feedback loop on limiting MAPK activity 
(Arthur and Ley, 2013). In periodontal cells, MAPK participates in the regulation of the 
expression of IL-6 and enzymes like MMP-1 and MMP-13, and elevated DUSP4 could be a 
protective mechanism to control MAPK activity (Craig et al., 2000; Johansson et al., 2000). 
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However, a previous study found that DUSP4 protein expression in gingival epithelial cells was 
decreased by periodontal pathogens, which was in contrast with our data showing a significant 
up-regulation of DUSPS mRNA in gingivitis (Hasegawa et al., 2007). One limitation of our 
study is that we did not have adequate biopsy samples to confirm protein expression levels, as 
our emphasis was on transcriptomic analysis.  
In addition, the expression of key insulin signaling molecules, namely IRS1, IRS2, SLC2A4 
(GLUT4), STX4, STXBP2 and PIK3R1 are all enhanced in experimental gingivitis. This suggests 
that locally acute inflammation up-regulates glucose metabolism by increasing local cellular 
uptake and glucose utilization. The IPA analysis as shown in Figure 2.2 confirms that pathway 
associated with carbohydrate metabolism is activated by acute inflammation. However, chronic 
inflammation associated with periodontitis was not as capable as acute inflammation in 
regulating glucose/insulin response genes as shown in Table 2.2. This suggests that in chronic 
inflammation there is some adaptation in the localized tissue response to create a more 
homeostatic glycolic local environment. Importantly, we had no naturally occurring gingivitis 
samples to compare in this study. However, we might expect them to have similar 
insulin/glucose profiles as periodontitis, if the naturally occurring gingivitis represents a chronic 
inflammatory processe. The finding of altered metabolism during acute induction might suggest 
that acute episodes of increased inflammation superimposed upon an existing chronic gingivitis 
or periodontitis may also be associated with enhanced insulin resistance and glucose utilization 
of the local periodontal tissues, but that will require experimental confirmation. 
In gingival tissues, glucose metabolism may be important not only for tissue metabolism 
but also affect microenvironment that supports the growth of periodontal pathogens. We 
appreciate that most subgingival species and most of the pathogens are assacharolytic. However, 
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the extension of the supragingival adherent plaque that contains saccharolytic bacteria into the 
subgingival pocket provides an important “feeder bed” to provide nutrients of intermediate 
metabolism including lactate and formate to support the metabolism of the assacharolytic 
organisms.  
We conducted a secondary analysis to consider the potential effects of obesity, because 
obesity affects both insulin responsiveness and periodontal disease (Franchini et al., 2011; 
Pischon et al., 2007). In Figure 2.4, certain genes are differentially regulated by obesity and this 
trend is more apparent in gingivitis group. More subjects are needed to study the modulatory 
roles of obesity. Studies have shown that obesity interacts with local gingival inflammation. 
Mizutani K et al showed that obese mice had selective insulin resistance in gingival tissues 
(Mizutani et al., 2014). In gingiva, specific miRNAs are differentially expressed in obese 
periodontitis compared to non-obese periodontitis subjects, suggesting that obesity may regulate 
genes post-transcriptionally (Perri et al., 2012). 
There were no statistical differences in race, gender, age, smoking history, or BMI in the 
study subjects. BMI were matched in subjects from each group to eliminate potential effects of 
obesity on insulin/glucose metabolism gene expression locally. It should be noted that the mean 
age of gingivitis group varies from those of the other groups, which raises questions about 
confounding effects of age on gene expression. Our analysis shows that adjusted fold regulation 
did not differ much from unadjusted fold regulation. This suggests that the markedly differential 
expression pattern we observed in gingivitis subjects was not affected by age. To further prove 
the interactions between age and insulin response gene expression, larger study subjects are 
needed. The application of PCR array allows us to have a more quantitative data compared to 
microarray. However, limitations of this study was that relatively few subjects were involved 
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limiting the generalizability of the findings, and we did not design the study to enable protein 
analysis. Although this is a pilot study with relatively few subjects (26 subjects), it demonstrates 
the utility of pathway analysis, which allows each molecular observation to contribute to the 
overall significance of networks.  
In conclusion, this study suggests that acute gingival inflammation may induce localized 
changes, which modify tissue insulin/glucose metabolism. But these changes are not evident in 
chronic periodontitis. Additionally, larger studies will be needed to confirm these findings to 
provide insights into understanding the association between gingival inflammation and 
periodontal tissue metabolism.  
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Table 2.1 Subjects demographics and clinical parameters  
  Healthy (N=8) Gingivitis (N=9) Periodontitis (N=9) P  
Age   45.9±4.9 37.0±3.0 46.2±4.9 0.2 
Female  5 5 5 0.9 
Caucasian  6 8 5 0.3 
Body mass 
index 
29.7±2.3 28.5±1.6 30.4±2.4 0.8 
<30  24.6±1.7 25.2±1.4 25.6±1.0 0.9 
>30 34.8±2.1 32.6±1.6 36.5±3.2 0.6 
Ex-smoker  2 2 4 0.5 
Probing depth 2.4±0.2 1.9±0.2 5.0±0.3 <0.001 
Attachment loss 0.5±0.2 1.0±0.2 3.9±0.6 <0.001 
Values are presented in mean ± standard error or n. 
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Table 2.2 Gene regulation in gingivitis and periodontitis subjects 
 
Gingivitis Periodontitis 
  
Fold change P value 
FDR  
P value  
Fold change P value 
FDR  
P value 
G6PD 14.11 0.000088* 0.0021 3.34 0.33 0.99 
IFNG 13.12 0.001* 0.0069 1.94 0.22 0.99 
CEBPA 10.39 0.00006* 0.0021 2.64 0.12 0.99 
DUSP4 9.9 0.0022* 0.0085 2.04 0.31 0.99 
PDX1 9.69 0.02* 0.038 1.42 0.91 0.99 
SNAP23 8.48 0.01* 0.037 1.86 0.67 0.99 
PRKCB 7.82 0.0014* 0.008 1.09 0.76 0.99 
PARP1 6.98 0.0019* 0.0084 3.4 0.28 0.99 
IRS1 6.69 0.0011* 0.0069 2.2 0.25 0.99 
STXBP2 6.66 0.0029* 0.01 2.25 0.56 0.99 
TRIB3 6.39 0.0041* 0.013 1.51 0.19 0.99 
IL12B 6.38 0.038* 0.087 1.2 0.66 0.99 
STX4 6.01 0.012* 0.031 2.01 0.95 0.99 
CCL5 5.06 0.93 0.96 2.67 0.51 0.99 
PIK3CD 5.06 0.00088* 0.0069 1.6 0.37 0.99 
IL6 5.02 0.14 0.28 1.98 0.65 0.99 
SREBF1 4.95 0.0029* 0.01 1.49 0.95 0.99 
PRKAG2 4.84 0.00038* 0.0045 2.09 0.12 0.99 
HNF4A 4.66 0.74 0.89 1.72 0.9 0.99 
NSF 4.56 0.00015* 0.0026 1.96 0.4 0.99 
SNAP25 4.43 0.0017* 0.0084 1.76 0.18 0.99 
PIK3C2B 4.37 0.001* 0.0069 1.08 0.71 0.99 
MAPK14 3.94 0.0019* 0.0084 2.05 0.33 0.99 
CCR2 3.83 0.1 0.21 1.18 0.92 0.99 
PPARGC1A 3.8 0.00022* 0.0031 1.16 0.31 0.99 
IRS2 3.71 0.0074* 0.022 1.37 0.89 0.99 
ACE 3.67 0.15 0.28 1.91 0.67 0.99 
PPARG 3.55 0.024* 0.058 1.56 0.95 0.99 
SELL 3.55 0.0031* 0.011 1.43 0.31 0.99 
HMOX1 3.46 0.00045* 0.0046 1.46 0.32 0.99 
ACLY 3.32 0.011 0.029 1.76 0.52 0.99 
NOS3 2.94 0.19 0.33 2.01 0.42 0.99 
NRF1 2.87 0.01* 0.029 1.28 0.46 0.99 
PTPN1 2.72 0.002* 0.0084 1.23 0.4 0.99 
VEGFA 2.7 0.17 0.3 2.02 0.51 0.99 
IL4R 2.69 0.99 0.99 5.68 0.9 0.99 
FOXC2 2.67 0.12 0.25 1.43 0.67 0.99 
VAMP3 2.62 0.000005* 0.0004 1.27 0.26 0.99 
NKX2-1 2.34 0.88 0.95 1.05 0.99 0.99 
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ME1 2.33 0.01* 0.018 0.96 0.71 0.99 
ICAM1 2.15 0.32 0.49 0.9 0.47 0.99 
FOXP3 2.1 0.83 0.95 1.4 0.91 0.99 
CEACAM1 1.85 0.21 0.34 0.91 0.48 0.99 
INS 1.65 0.91 0.95 0.91 0.7 0.99 
GSK3B 1.65 0.0019* 0.0084 0.89 0.47 0.99 
PPARGC1B 1.61 0.59 0.79 1 0.61 0.99 
SLC2A4 1.54 0.48 0.68 0.73 0.71 0.99 
FBP1 1.41 0.9 0.95 2.02 0.36 0.99 
IGFBP5 1.38 0.66 0.82 1.73 0.54 0.99 
MAPK8 1.31 0.18 0.31 0.97 0.86 0.99 
CTLA4 1.31 0.57 0.78 1.26 0.82 0.99 
TNFRSF1A 1.29 0.99 0.99 0.88 0.57 0.99 
PRKAA1 1.27 0.66 0.82 2.27 0.69 0.99 
VAPA 1.26 0.08 0.18 0.93 0.4 0.99 
PPARA 1.25 0.61 0.81 1.04 0.91 0.99 
RAB4A 1.21 0.65 0.82 1.81 0.8 0.99 
AGT 1.05 0.16 0.29 0.65 0.21 0.99 
INPPL1 0.96 0.85 0.95 0.85 0.59 0.99 
INSR 0.87 0.85 0.95 1.08 0.64 0.99 
IKBKB 0.87 0.42 0.62 1.28 0.52 0.99 
FOXG1 0.87 0.29 0.46 0.47 0.16 0.99 
ENPP1 0.78 0.91 0.95 1.05 0.87 0.99 
NFKB1 0.68 0.09 0.2 0.81 0.34 0.99 
TNF 0.65 0.16 0.29 0.87 0.83 0.99 
IL10 0.62 0.75 0.89 1.17 0.9 0.99 
PIK3R1 0.6 0.47 0.67 0.59 0.35 0.99 
IDE 0.5 0.39 0.59 1.75 0.73 0.99 
AKT2 0.45 0.5 0.69 0.97 0.89 0.99 
CD28 0.42 0.2 0.33 0.54 0.22 0.99 
STXBP1 0.28 0.77 0.9 0.77 0.98 0.99 
TGFB1 0.23 0.68 0.83 0.66 0.99 0.99 
              
Fold changes are calculated through the delta-delta threshold cycle method; P values are 
generated by Student’s t tests, followed by a false discover rate adjustment. *Statistical 
significance after the false discover rate adjustment, P < 0.05. 
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Table 2.3 Fold Regulation Adjusted by Age for 4 Genes 
  G6PD IFNG CEBPA DUSP4 
  
Crude  
FR 
Adjusted  
FR 
Crude  
FR 
Adjusted 
FR 
Crude  
FR 
Adjusted 
 FR 
Crude  
FR 
Adjusted 
 FR 
Healthy 2.54 2.34 2.42 2.10 1.70 1.53 1.69 1.65 
Gingivitis 15.33* 15.73* 19.46* 20.10* 11.35* 11.69* 12.32* 12.41* 
Periodontitis 4.13 3.90 4.39 4.03 3.65 3.46 2.65 2.60 
* P<0.05, computed from multiple linear regression modess; FR: Fold Regulation 
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Figure 2.1 Volcano plot presenting regulation of insulin response genes comparing diseased to 
healthy subjects. The vertical axis refers to the -log10 (p-value) for t-test of differences between 
groups; the horizontal axis refers to log2 (fold change) as expression levels. Red and green dots 
represent up-regulated (>2-fold) and down-regulated (<2-fold) genes respectively. Black dots are 
genes that are within 2-fold regulation. The clustering of red dots within the upper right quadrant 
are statistically significant genes (p<0.05). A) 45 genes are up-regulated >2-fold in experimental 
gingivitis group and 32 of them are statistically significant; 5 genes are down-regulated >2-fold 
in the same group but none of them reach significant. B) 15 genes are up-regulated >2-fold and 1 
gene is down-regulated >2-fold in chronic periodontitis group, but none of them is significant. 
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Figure 2.2 Ingenuity pathway analysis comparing diseased to healthy subjects. Red nodes are up-
regulated genes; green shapes are down-regulated genes. Genes that are associated with these 
key network molecules but not included in the polymerase chain reaction array are not colored. 
Straight lines represent direct interaction, and dotted lines represent indirect interaction. A) 
Functions and scores of 5 activated networks in gingivitis subjects are listed. The top-ranked 
network comprises endocrine disorders, metabolic disease, and carbohydrate metabolism 
functions (score=25). The majority of molecules in this network are up-regulated. Only 2 
molecules are down-regulated. B) Functions and scores of 4 activated networks in periodontitis 
subjects are listed. The 2nd ranked network comprises carbohydrate metabolism, small molecule 
biochemistry, cell death and survival (score=14). The majority of molecules in this network are 
up-regulated.  
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Figure 2.3 G6PD protein increases by E. coli LPS stimulation. HGEPs were treated with E.coli 
LPS (1ug/ml) for 0, 4, 8 and 24h and blotting for G6PD showed protein up-regulation. 
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Figure 2.4 Fold change ratio of obesity/non-obese diseased subjects. Gene fold changes are 
normalized against non-obese healthy subjects. A) The ratio of obese/non-obese in gingivitis 
subjects is plotted. If the ratio is below zero, gene expression in obese subjects is lower than non-
obese subjects; if the ratio is above zero, gene expression in obese subjects is higher than non-
obese subjects. 
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Abstract 
Background: The presence and accumulation of advanced glycation end products (AGEs) in 
gingiva has been evident in chronic periodontitis patients, which is even more drastic among 
those who have diabetes. We conducted this study to examine whether transcription of key 
regulatory genes in gingival wound healing and migration were affected by AGEs in gingival 
fibroblast.  
Methods: AGEs were prepared in vitro using bovine serum albumin (BSA) as a carrier. Human 
gingival fibroblast (HGF-1) was pretreated with AGEs-BSA (1ug/ml) for 24h, then stimulated 
with AGEs-BSA (1ug/ml) with E.coli LPS (0, 100, 1000ng/ml) for 24h. Total RNA was 
extracted and reverse transcribed to cDNA. qRT-PCR was performed to detect the transcription 
of prostaglandin-endoperioxide synthase 2 (PTGS2), matrix metalloproteinase 1 (MMP1), and 
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fibroblast growth factor 2 (FGF2) genes. Scratch assay and transwell assay were conducted to 
examine the migration activity of gingival fibroblast affected by AGEs. HGF-1 that was 
pretreated and stimulated with BSA served as controls. 
Results: Compared to BSA treated cells, HGF-1 that was pretreated and stimulated by AGEs-
BSA and LPS showed significantly increased transcription of PTGS2, MMP1 genes, but not 
FGF2 gene. AGEs-BSA treated cells displayed a delayed migration as proved by the scratch 
assay and transwell assay.  
Conclusion: AGEs inhibit gingival fibroblast migration. PTGS2, MMP1 mRNA is increased by 
AGEs and LPS stimuli, which may explain the accelerated periodontium destruction during 
chronic periodontitis, especially under the diabetic background.  
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Introduction 
Periodontal disease and diabetes mellitus especially type 2 diabetes (T2DM) share a 
bidirectional relationship (Mealey et al., 2006). Periodontal disease adds a burden of systemic 
inflammation by inducing pro-inflammatory cytokines including TNF-a, IL-6, and IL-1β (Page, 
1991). These cytokines are known to activate insulin resistance, which occurs at the beginning 
state for T2DM and a later state for T1DM. Periodontal disease may lead to severe consequences 
in the diabetic population. In a study conducted among Pima Indians with T2DM, severe 
periodontitis significantly increased the mortality rate from diabetic nephropathy and ischemic 
heart disease (Saremi et al., 2005). Treating periodontal disease, on the other hand, improves the 
glycemic controls for diabetic patients (Teeuw et al., 2010). From the perspective of how 
diabetes affects periodontal disease, many mechanisms have been proposed and one possible 
mechanism is the influence of advanced glycation end products (AGEs).   
AGEs are a heterogeneous group of non-enzymatically formed proteins from having a 
sustained contact with sugars. For diabetic subjects, their tissues and organs have higher AGEs 
accumulations than those of non-diabetic subjects. Receptor for AGEs (RAGE) has been found 
to interact with AGEs and triggers the downstream NF-κB pathway (Schmidt et al., 1994). As a 
result, inflammation and reactive oxygen species are elevated, which subsequently change the 
physiology of the tissues. Accumulations of AGEs are evident in gingival tissues. AGEs 
aggregate more potently in the gingival epithelium and the underlying connective tissues among 
diabetic subjects compared to their non-diabetic counterparts (Abbass et al., 2012; Zizzi et al., 
2013).  
Emerging evidence has shown that AGEs might be associated with impaired wound healing 
in diabetes. Systematically blocking RAGE improves skin repairs in diabetic mice (Goova et al., 
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2001). Chang PC et al found that anti-AGEs agents facilitated the palatal gingival wound healing 
by reducing inflammation (Chang et al., 2014). During the gingival wound healing process, 
connective tissue has a unique role in tissue remodeling. Gingival fibroblast, as the most 
abundant resident cells in the connective tissue, is a reservoir for inflammatory cytokines (eg. IL-
1β, TNFα, PGE2), effector molecules (eg. MMPs, TIMPs), and growth factors (eg. FGF, CTNF). 
All these molecules actively participate in the tissue remodeling process. Fu Y et al found that 
AGEs induced MMP1 productions in human gingival fibroblast through activating NF-κB 
pathway, which further indicated the importance of AGEs on periodontal disease. However, 
whether AGEs affect anabolic growth factors and whether AGEs inhibit gingival fibroblast 
migration in vitro remain unknown.  
The objective of this study is to investigate effects of AGEs on gingival fibroblast migration 
and gene regulation. We hypothesized that AGEs inhibited gingival fibroblast migration. 
Additionally, AGEs increased transcription of genes that were associated with inflammatory 
cytokines and effector molecules, but not anabolic growth factor genes.  
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Material and Methods 
Preparation of AGEs-BSA compounds 
AGEs-BSA compounds were prepared by incubating BSA at a 1mM concentration with 1M 
glucose, 1.5mM phenylmethanesulfonyl fluoride, and 1% penicillin-streptomycin in phosphate-
buffered saline (PBS) solutions (ph=7.4), at 37°C for 10 weeks. Same compositions without 
glucose were incubated simultaneously as BSA controls. Both AGEs-BSA and BSA solutions 
were dialyzed against PBS using 20K MWCO dialysis cassettes, at 4°C overnight. We then used 
Bradford protein assay (Sigma) to quantify for the concentration of BSA in both groups. BSA 
and AGEs-BSA were diluted to a concentration of 1mg/ml and stored at -80°C until use.   
Cell culture and in vitro stimulations 
HGF-1 was purchased from ATCC (CRL-2014) and maintained in DMEM low glucose 
medium (Gibco) supplemented with 10% fetal bovine serum (FBS, Gibco) and 1% penicillin-
streptomycin (Invitrogen). We seeded HGF-1 in 6 well plates at a density of 2x105 and changed 
the medium every other day until AGEs challenges began. AGEs-BSA or BSA compounds were 
added to HGF-1 culture for 24h. The medium was then switched to E. coli LPS (0, 100ng/ml, 
1000ng/ml, strain 55 O:H) containing medium in the continuing presence of AGEs-BSA or BSA 
for 24h. At the end, cells were harvested for RNA isolation.  
RNA isolation and qRT-PCR 
Total RNA was isolated from HGF-1 cells using RNeasy Mini kit. RNA quality and quantity 
were measured by nanodrop. 500ng total RNA was reverse transcribed to cDNA. Gene 
expression was examined using qRT-PCR in a 7500 Sequence Detection System (ABI Prism, 
Applied Biosystems). Taqman primers for PTGS2, MMP1 and FGF2 genes were purchases from 
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ABI expression (Hs00153133_m1, Hs00899658_m1, Hs00266645_m1). The mRNA expression 
levels were normalized using 18s ribosome RNA as the housekeeping gene.  
Migration Assay 
In the transwell migration assay, HGF-1 cells were undergoing BSA or AGEs-BSA treatment 
in the absence of serum overnight. 2x104 cells were added to the upper well of the transwell 
inserts (Millipore, 6.5mm2). Inserts were then immersed into medium containing BSA or AGEs-
BSA (10, 100, 1000ng/ml) in the presence of 30% FBS (chemo-attractant) in a 24 well plate. 
Following 12h of migration, inserts were removed from the culture plate and fixed with 4% 
paraformaldehyde at room temperature for 10mins, followed by 1XPBS washing 3 times. We 
applied a cotton swap to clean the remaining cells apically. The last step was to stain the nuclei 
using DAPI solution (D1306, Invitrogen) for 5mins, avoiding lights. Nuclei staining were read 
under a fluorescent microscopy (EVOS). For each insert, 5 fields (four corners and a central spot 
from a cross) were chosen to count for the average cell numbers. In the scratch assay, 2x105 
HGF-1 cells were seeded into 6-well plates until they formed a monolayer. After overnight 
serum starvation, cell monolayers were scraped with a sterile 200ul pipette tip in the midline. We 
immediately aspirated the culture medium, rinsed the cells with 1XPBS 3 times, and added 
medium containing either BSA or AGEs-BSA. Both medium were supplemented with 30% FBS. 
After 12h of migration, cell images were captured from an inverted phase contrast microcopy. 
Two scratch wounds were made for each treatment and two independent experiments were 
performed. Image J software was used to quantify for the wound closure percentage.   
Statistical Analysis 
Fold changes are calculated through the delta-delta threshold cycle method. P values are 
generated by Student’s t-tests. Significance level was set at 0.05.   
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Results 
Predisposing to AGEs enhances gingival fibroblast PTGS2 and MMP1, but not FGF2 
mRNA expression in response to LPS 
In order to investigate effects of AGEs on gingiva fibroblast gene regulation, we stimulated 
HGF-1 with AGEs-BSA or BSA for 24 hours and examined mRNA expression of representative 
genes. To optimize the dosage of AGEs-BSA, we treated HGF-1 with AGEs-BSA at 10, 100 and 
1000ng/ml for 24h and measured PTGS2, MMP1 and FGF2 mRNA expression. HGF-1 tolerated 
all three dosages of AGEs-BSA without visible cellular changes (data not shown). To this end, 
we continued using AGEs-BSA at a concentration of 1000ng/ml. To our surprise, PTGS2, 
MMP1 and FGF2 mRNA levels did not differ between AGEs-BSA and BSA treatments (Figure 
3.1A). We then adjusted the in vitro model by pretreating HGF-1 with AGEs-BSA or BSA for 
24h and stimulated cells with E. coli LPS (0.1ug/ml, 1ug/ml) in continuing presence of AGEs-
BSA or BSA for another 24h. We found that LPS significantly increased MMP1 and PTGS2 
mRNA expression in a dosage dependent manner while pretreatment of AGEs-BSA significantly 
enhanced their mRNA expression (Figure 3.1B and 3.1C). However, FGF2 mRNA was not 
significantly altered by either AGEs-BSA or LPS treatment (Figure 3.1D).    
AGEs inhibit gingival fibroblast migration 
In addition to gene regulation, we hypothesized that AGEs may inhibit gingival fibroblast 
migration in vitro. In order to test our hypothesis, we utilized two types of migration assays. In 
the transwell assay, HGF-1 cell migration was clearly inhibited by AGEs-BSA with fewer 
numbers of cells counts (Figure 3.2A, P<0.05).  In the scratch assay, the wound closure 
percentage was significantly smaller in AGEs-BSA treatment compared to BSA treatment, which 
confirmed with the transwell assay results (Figure 3.2B). 
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Discussion 
In this study, we have proved that predisposing gingival fibroblast to AGEs enhances PTGS2 
and MMP1, but not FGF2 gene transcription in response to LPS stimulations. AGEs appear to 
inhibit gingival fibroblast migration. Our data suggests that accumulations of AGEs in gingival 
tissue during diabetes may accelerate periodontium destruction and impair gingival wound 
healing.  
The transcription of PTGS2 gene is tightly coupled with PGE2 productions. PGE2 is a 
vasodilator that engages in increasing vascular permeability and promoting inflammation that 
leads to periodontium destruction (Offenbacher et al., 1993). Therefore, PGE2 is a well-
established inflammatory biomarker for periodontal disease. Empirically, monocytes and 
macrophages are thought be the major source for PGE2 production. However, gingival fibroblast 
potently produces PGE2 in gingival tissues as well (Bage et al., 2011). MMP1 is a collagenase 
that regulates ECM, therefore influences both gingival wound healing and periodontium 
destruction. Yu S et al has shown that AGEs induce MMP1 mRNA through RAGE/ NF-κB 
pathway in gingival fibroblast (Yu et al., 2012). Since MMP1 degrades collagen, it is not 
surprising to observe that AGEs inhibit type I and III collagen synthesis in gingival fibroblast 
(Ren et al., 2009). FGF2 is an anabolic growth factor that promotes fibroblast migration during 
periodontal regeneration (Kitamura et al., 2008). FGF2 is absent from gingival epithelium, but 
stained potently in connective tissue fibroblast (Takayama et al., 2002).  
Our data shows that AGEs modifications alone do not affect gene transcription. Since AGEs 
compounds are not commercially available, every laboratory has different formulas for making 
AGEs. This is likely to be a reason for the different responses we have observed in the study. 
However, this does not suggest AGEs are not functioning. It is clear that LPS increase both 
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PTGS2 and MMP1 transcription and predisposing fibroblast to AGEs almost doubles the 
expression (Figure 3.1B and 3.1C). Elevations of PTGS2 and MMP1 cause periodontal 
destruction. When AGEs accumulate in the gingival tissues during diabetic periodontitis, 
gingival fibroblast becomes more sensitive to a 2nd stimulus from bacterial challenges. 
According to this study, FGF2 is unlikely to be regulated by LPS or AGEs (Figure 3.1.D).  
Failure of induction of FGF2 supports that in periodontitis especially when combined with 
diabetes, repair of gingival fibroblast might be delayed.  
Hyperglycemic condition in diabetes impairs wound healing and AGEs are potential 
regulators. The interaction between AGEs and RAGE activates the downstream signaling 
pathways that lead to pro-inflammatory cytokine productions. These chains of events may alter 
the cytoskeleton architecture and eventually regulate migratory abilities of cells. This study 
confirms with the existing concepts that AGEs are causally associated with severe periodontium 
destruction. The innovative discoveries of AGEs inhibiting gingival fibroblast migration further 
shed lights on potential drug development for improving gingival wound healing.  
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Figure 3.2 Prior exposures of AGEs enhance gingival fibroblast response to LPS. A) Gene 
regulation fold changes do not differ between AGEs-BSA and BSA treatments. B) and C) 
PTGS2 and MMP1 transcriptions increase by LPS stimulations in a dosage dependent manner 
and AGEs significantly enhance the responses (* indicates p<0.05). D) LPS or AGEs do not 
regulate FGF2 transcription in HGF-1. Error bar represents standard error. 
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Figure 3.1 AGEs inhibit gingival fibroblast migration. A) Representative staining images show 
that AGEs inhibit fibroblast from migrating out of the transwell inserts. There are significantly 
more migratory cells in the BSA group than those of AGEs-BSA group (* indicates p<0.05).  
Scale bar represents 400um. B) The percentage of scratch closure is relatively smaller in BSA 
group compared to those from AGEs-BSA group. 
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CHAPTER 4: IMPAIRED FUNCTION OF EPITHELIAL PLAKOPHILIN-2 IS 
ASSOCIATED WITH PERIODONTAL DISEASE 
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Abstract 
Objectives: Plakophilin-2 (PKP2) is a structural protein of desmosomes that assists in 
maintaining the integrity of the epithelium barrier. A previous genomic wide association study in 
our lab has discovered a statistically significant association between multiple SNP variants of 
PKP2 gene and periodontal disease. Key desmosome molecules Desmoglein 1 and Desmocolin 1 
were compromised in periodontitis. For these reasons, we initiated studies to elucidate the role of 
PKP2 in periodontal disease. 
Methods: Gingival biopsies were harvested from 11 healthy, 10 experimental gingivitis and 10 
chronic periodontitis subjects. We examined PKP2 mRNA and DNA methylation patterns in 
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these biopsies. Primary human gingival epithelial cells (HGEPs) were challenged by 
Porphyromonas gingivalis (P.g), Campylobacter rectus (C.r), or multiple TLR agonists. Medium 
was switched to high calcium condition to examine the effect of calcium on desmosome 
molecules. The alteration of protein was detected by western blot or immunofluorescence 
staining. We further knocked down PKP2 in HEGPs using short hairpin RNA (shRNA) to study 
cell proliferation, spreading, and barrier functions in the lack of PKP2.  
Results: PKP2 mRNA was significantly decreased in gingival biopsies from chronic 
periodontitis comparing to healthy subjects (p<0.05). Using the same biological samples, we 
found an increase of DNA methylation in the promoter region of PKP2 that might be associated 
with PKP2 down-regulation. Epithelial PKP2 mRNA was enhanced by P.g stimulation, but 
protein expression differed. Both PKP2 and DSG1 proteins were decreased by viable P.g, but not 
by C.r or heat killed organisms, suggesting their selective degradations by P.g. The addition of 
the proteasome inhibitor MG132 and lysosome inhibitor NH4Cl did not prevent degradation, but 
cysteine proteases inhibitors greatly attenuated PKP2 degradation by viable P.g. In vitro 
stimulation of P.g and C.r both increased the overall PKP2 DNA methylation level. Epithelial 
cells with deficient PKP2 had inhibited cell proliferation and spreading. Decreased PKP2 was 
associated with impaired cell barriers.  
Conclusions: PKP2 protein expression is suppressed in gingival epithelial cells associated with 
periodontal disease. Cysteine proteases made by P.gingivalis selectively degrade PKP2. PKP2 
deficiency potentiates epithelial homeostasis. These data suggest that PKP2 may play an 
important role in maintaining epithelial integrity thus have an important protective role in the 
etiopathogenesis of periodontal disease. 
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Introduction  
An imbalanced biofilm-gingival interface is the key to the onset of periodontal disease. 
Gingival epithelium, the outmost layer of gingiva, creates a physical barrier to minimize 
bacterial invasions thus is regarded as an early line of defense against periodontal pathogens 
(Schroeder and Listgarten, 1997). Disruptions of gingival epithelial cells (GEC) barrier allow 
bacteria and bacterial products to enter into the underlying tissues, trigger immune responses and 
cause bone resorptions. Intact cell-to-cell adhesions are crucial for GEC barrier and are consist of 
many intercellular junctions, including tight junctions, adherens junctions, gap junctions, and 
desmosome junctions.  
Desmosome junctions reside in gingival epithelium and have complex structural components 
(Green and Gaudry, 2000; Hatakeyama et al., 2006). In desmosomes, Desmoglein (DSG) and 
Desmocollin (DSC) are extracellular cadherin molecules, while plakophilin (PKP), plakogloblin, 
and desmoplakin are intracellular components that bridge intermediate filaments and 
desmosomes. DSG1 and DSC1 mRNA were found to be decreased in gingival biopsies from 
periodontitis patients compared to healthy subjects (Abe et al., 2011). However, whether PKP is 
altered in periodontal disease remains unknown and whether the change leads to the 
pathogenesis of periodontal disease is yet to be discovered.   
PKP has four members (PKP1, PKP2, PKP3, and p0071) and PKP2 is the best-characterized 
member. Mutations of PKP2 cause a severe inherited heart disease-arrhythmogenic right 
ventricular cardiomyopathy, and PKP2 null mice exhibit embryonic lethality due to heart 
morphogenesis defects, suggesting that lack of PKP2 leads to severe consequences (Grossmann 
et al., 2004; van Tintelen et al., 2006). Functions of PKP2 are not limited to structural molecule 
of desmosome junctions. PKP2 interacts with epidermal growth factor receptor, a growth factor 
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that is tightly coupled with cell proliferation (Arimoto et al., 2014; Kazlauskas, 2014). PKP2 
deficient keratinocytes display a delayed migration through altering the focal adhesion (Koetsier 
et al., 2014). Additional study has shown that PKP2 directly interacts with β-catenin to potentiate 
TCF/LEF1 mediated transcription of target genes as part of Wnt signaling pathways (Chen et al., 
2002).  
DNA methylation is an epigenetic modification that controls gene expression. Many groups 
including us have found that aberrant DNA methylation patterns of several inflammatory genes 
are associated with periodontitis (Andia et al., 2010; Zhang et al., 2013). Periodontal pathogens 
can alter DNA methylation machinery to regulate genes encoding antimicrobial peptides as well 
(Yin and Chung, 2011). In a recent study, membrane bound protein TLR2 can be modified by 
DNA methylation mechanism in periodontitis patients (Benakanakere et al., 2015). This finding 
suggests that structural protein could be modified by DNA methylation. Therefore, the goal 
study is to investigate the association between PKP2 function and periodontal disease and what 
mechanisms are involved in PKP2 regulation.  
 
 
 
 
 
 
 
 
 
67 
Material and Methods 
Participants Selection 
Thirty-one participants, aged 19 to 64, provided informed consent and were recruited in the 
dental clinics from School of Dentistry at University of North Carolina at Chapel Hill. All 
procedures were approved by Institutional Review Board (IRB) of the University of North 
Carolina at Chapel Hill. Participants were sequentially enrolled with either periodontally healthy, 
experimental gingivitis or chronic periodontitis with the following exclusion criteria: 1. No use 
of antibiotics within one month before the screening examinations; 2. No signs of systemic 
diseases with any oral manifestation at the time of the enrollment; 3. No self-reporting treatment 
for systemic diseases three months prior to the collections of gingival biopsies. Basic 
demographic information and routine periodontal clinical parameters were recorded for each 
subject.   
Eleven periodontally healthy participants were either healthy volunteers or patients who 
were undergoing crown lengthening procedures and they exhibited ≤ 4mm probing depth (PD), 
no signs of bleeding on probing (BOP) at the biopsy site, and no evidence of bone loss 
radiographically. Ten chronic periodontitis patients representing chronic inflammation were 
enrolled with exhibitions of > 5mm of PD, presence of BOP and radiographic demonstration of 
bone loss. Ten experimental gingivitis patients representing acute inflammation were acquired 
from a 3-week stent-induced biofilm overgrowth procedure (Offenbacher et al., 2009). A 
gingival biopsy was obtained from each subject at the site of interproximal papillae and 
composed of epithelium and connective tissues. Gingival biopsies were acquired at the severely 
inflamed interproximal site during a periodontal flap surgery for periodontitis subjects and for 
experimental gingivitis patients, gingival biopsies were obtained at the end of 3 weeks of 
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inductions. Upon harvesting, all biopsies were divided into three portions for genomic DNA 
isolation, RNA isolation, and immunofluorescence staining according to different preservation 
methods.  
In vitro stimulation of HGEPs with bacteria  
P.g strain A7436 were grown in defined Wilkins-Chagren (Thermo Scientific) broth medium 
anaerobically under 37°C for up to 5 days. When the optical density reached 0.5, the 
concentration of P.g equaled 109 CFU/ml. C.r strain 314 were grown on an ETSA plate (Thermo 
Scientific) anaerobically for up to 3 days. When the optical density reached 1.0, the 
concentration of C.r equaled 109 CFU/ml. HGEPs were purchased from CellnTec and maintained 
according to the manufacture’s instructions. Bacterial cells were pelleted at a speed of 6000g for 
15mins, washed with 1XPBS twice, and reconstituted in the cell culture medium. HGEPs were 
seeded at a density of 5X105 in 6 well plates and treated with P.g at the multiplicity of infection 
(MOI) at 10, 50, or 100 for up to 24h. HGEP were treated with C.r at MOI 50 or 100 for up to 
24h. Both P.g and C.r were placed in a 70°C heat block to be heat-killed to serve as control 
bacteria.  MG132 and NH4Cl were directly added into the cell culture; pefabloc SC, cathepsin B 
inhibitor, and leupeptin (Roch) were co-cultured with P.g in the anaerobic chamber for 1h before 
being added into the cell culture.  
RNA isolation and quantitative real-time PCR 
Total RNA was isolated from gingival biopsies or HGEP cells using RNeasy Mini kit 
(Qiagen). RNA quality and quantity were measured by nanodrop. 500ng total RNA were reverse 
transcribed to cDNA using Invitrogen vilo kit (Invitrogen). Gene expression was examined using 
quantitative real-time PCR in a 7500 Sequence Detection System (ABI Prism, Applied 
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Biosystems). The mRNA expression levels were normalized using 18s ribosome RNA as the 
housekeeping gene.  
Cell lysates preparation and western blot 
Whole cell lysates were collected using RIPA buffer (cell signaling) that were supplemented 
with protease inhibitor cocktail and phospho stop (Roch). We then used DC protein assay 
(Biorad) to quantify the total protein concentrations. The same amount of protein from each 
sample was aliquoted, mixed with 4x sample buffer (Invitrogen), and boiled on a heater (80°C) 
for 10mins to reduce the protein contents. Proteins were loaded into the NuPAGE Novex 4-12% 
Bis-Tris Gels to separate protein bands and transferred to a nitrocellulose membrane paper. 
Membranes were blocked with 5% skim milk in TBST for 45mins. Anti-PKP2 antibody (1:200 
dilution, C-1, santa cruz), anti-DSG1 antibody (1:200 dilution, H-290, santa cruz), anti-DSC2/3 
antibody (1:200 dilution, 7G6, santa cruz), and anti-β actin antibody (1:1000 dilution, 13E5, cell 
signaling) were incubated with the membranes overnight at 4°C. Specific HRP conjugated 
secondary antibodies (anti-mouse Sigma; anti-rabbit Jackson Lab) were incubated for 1hour at 
room temperature and ECL system (SuperSignal West Pico; Pierce) was used to detect the 
intensity of the bands.  
Genomic DNA isolation, bisulfite conversion, bisulfite specific PCR, and Pyrosequencing 
Genomic DNA was isolated from the collected gingival biopsies samples using a DNeasy 
Mini Kit (Qiagen). A total of 500ng genomic DNA was quantified and undergoing bisulfite 
conversion using Epitect Bisulfite kit (Qiagen).  After the conversion, all unmethylated cytosines 
in the non-CpG sites of the genomic DNA were converted to thymines. We chose a promoter 
region about 600bp upstream of the transcription starting site of PKP2 gene and this was 
illustrated in Figure 4.1. For methylation analysis, we amplified a designated region (referred as 
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amplicon), which contained a total of 5 CpG sites using a HotStar Taq kit (Qiagen). Primers 
needed for this bisulfite-specific PCR were listed in Table 4.1. PCR condition for this amplicon 
can be found in Table 4.2. Direct quantification of the ratio of methylated to unmethylated 
cytosine nucleotide for each analyzed CpG site present was determined by pyrosequencing with 
the PSQ HS 96 Pyrosequencing System (Biotage) and Pyro Gold CDT Reagents (Qiagen) as 
previously described (Zhang et al., 2013).  
Methylation PCR assay 
To study whether bacteria could alter DNA methytlation machinery for PKP2 gene in a short 
period of time, we treated HGEPs with P.g or C.r for 24h and detected the overall methylation 
levels of PKP2 gene. 500 ng of genomic DNA were isolated and digested using EpiTect Methyl 
II DNA Restriction Kit (Qiagen). Digested DNA was then quantified by qPCR using EpiTect 
Methyl II PCR Primer Assay for Human PKP2 (CpG Island 103034, EPHS103034-1A). Data 
analysis was done using integrated Excel-based templates provided by the manufacturer, which 
provided gene methylation status as percentage unmethylated (UM) and percentage methylated 
(M) fraction of input DNA. M represents the fraction of input genomic DNA containing two or 
more methylated CpG sites in the targeted region of a gene. A relative methylation fold change 
to controls was reported.  
Calcium switch and immunofluorescence staining  
5X104 HGEPs cells were seeded in 24-wells glass bottom plates that were coated with 
10ug/ml Fibronectin (Sigma). When cells reached 80% confluence, the initial low calcium 
(0.07um) containing cell culture medium were switched to high calcium (1.8mM) containing 
medium over night to get a monolayer sheet. Cells were then stimulated with P.g at MOI: 50 for 
another 24h. At the end of the stimulation, cells were fixed with 4% paraformaldehyde for 
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10mins, permeablized with 0.1% Triton X-100 in PBS for 30mis, and blocked with 1% 
BSA/PBS/0.1% triton x-100 at RT for 1h. Anti PKP2 and anti DSG1 antibodies (1:200 dilutions) 
were incubated overnight at 4°C. Secondary antibodies (Alexa Fluoro 488 for Anti-PKP2, Alexa 
Fluoro 590 for Anti-DSG1) were incubated at the1:200 dilution at RT for 1h, avoiding the light. 
We then observed cell staining under a confocal micros copy (Zeiss LSM 710). 
PKP2 knocked down in HGEPs 
In order to test our hypothesis that the reduced epithelial PKP2 is functionally associated 
with periodontal disease, we knocked down PKP2 using short-hairpin RNA (shRNA) and 
examined the alterations of cell physiology. One scramble shRNA (Addgene) and five PKP2 
targeted shRNA bacterial glycerol stocks (Sigma Aldrich) were grown in lysogeny broth for 16h 
at 37°C and plasmids DNA were isolated using NucleoBond Xtra Midi kit (Clonetech). Target 
sequences of shRNA and scramble RNA were listed in Table 4.4. We sent these plasmids DNA 
to the lenti-shRNA core facility at UNC-Chapel Hill to assemble lentiviral particles. Upon 
receiving the lentiviral containing medium, we preserved them in -80°C until use. HGEPs were 
treated with the designated lentiviral mediun for 48h and switched to medium containing 
puromycin (2ug/ml, MP Biomedicals) for up to 7 days for selections.  Knocked down efficiency 
was determined by western blot. We compared cell proliferation using MTS assay (CellTiter 96 
® Aqueous) and cell spreading using direct phase contrast microscopic images between the 
scramble control and PKP2 knocked down cells.  
Epithelial barrier test 
We conducted a barrier test using Fluorescein isothiocyanate-dextran (FITC-Dextran, sigma) 
to test for whether lack of PKP2 impaired the epithelial barrier. 4x105 HGEPs that were either 
treated by PKP2 shRNA and scramble shRNA were seeded into fibronectin-coated transwell 
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inserts. FITC-Dextran (1mg/ml) was added to the top compartment of each inserts.  In a parallel 
experiment, we seeded 4x105 normal HEGPs were added into the transwell inserts. FITC-
Dextran, together with different P.g (live 1010 CFU/ml, live 109 CFU/ml, heat-killed 109 CFU/ml) 
was added to the top compartment of the inserts. Inserts were all immersed in culture medium in 
24-well plates. 5 hours later, cell culture medium were removed from the bottom well and 
measured for fluorescence on a microplate reader using 485nm/530nm excitation-emission filter.  
Statistical Analysis 
Statistical significance was determined by student t-test or one-way ANOVA for most 
assays. Chi square test was used for categorical variables. In gene expression data, the 
differences within groups were evaluated by LSD test. Statistical significance was established at 
p<0.05. Three replicates were used in each treatment and every experiment was repeated at least 
twice.  
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Results 
Epithelial PKP2 transcription is decreased in gingival biopsies from periodontitis 
 For three groups of biopsies, subjects’ demographics and clinical parameters were listed in 
Table 4.3. Compared to gingival biopsies from healthy and experimental gingivitis subjects, 
those of chronic periodontitis subjects had significantly decreased PKP2 mRNA transcripts 
(Figure 4.2A). To quantify for the epithelium portion of the gingival biopsies, we used Keratin 5 
(KRT5) as a marker. No significant differences were detected in KRT5 mRNA transcripts 
between three comparison groups (Figure 4.2B).  We later divided PKP2 fold induction by KRT5 
fold induction for each sample and plotted the adjusted fold inductions and still found that 
periodontitis biopsies displayed significantly fewer PKP2 mRNA transcripts (Figure 4.2C). 
These results suggest that decreased epithelial PKP2 mRNA is associated with periodontitis.  
PKP2 protein is degraded by P. gingivalis through cysteine proteases 
PKP2 and DSG1 proteins were decreased when P.g challenges were at MOI of 50 or 100 
(Figure 4.3A). Contrary to the protein data, viable P.g increased PKP2 mRNA expression 
(Figure 4.3B). This discrepancy suggests PKP2 protein degradation instead of decreased protein 
synthesis. Heat-killed P.g did not alter PKP2 on mRNA or protein levels, indicating effects of 
viable P.g may be due to active proteinases. We then conducted a time and dosage course 
experiment and confirmed that the degradation of PKP2, DSG1 was in a time and dosage 
dependent manner (Figure 4.3C). Since sustained bacterial challenges enhance inflammation, our 
next step is to see whether inflammation changes PKP2 expression. LPS is an ideal stimulus to 
mimic the in vitro inflammation. LPS from E.coli, P.g W83, and P.g A7436 LPS did not affect 
PKP2 and DSG1 protein expression, but TNF-α seemed to induce protein expression (Figure 
4.3D). Both viable and heat-killed C.r challenges did not alter PKP2 and DSG1 proteins (Figure 
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4.3E). Since viable P.g specifically degraded PKP2 and DSG1 proteins, we next looked into the 
potential extracellular and intracellular degradation pathways. Extracellular degradation may be 
caused by cysteine or serine proteases, which are possessed in the Gingipain-a major virulent 
factor of P.g. Two major intracellular degradation mechanisms are proteasomal degradation and 
lysosomal degradation pathways. Both MG132 (proteasomal degradation inhibitor) and NH4Cl 
(lysosomal degradation inhibitor) did not restore the protein of PKP2 and DSG1 degradation by 
P.g (Figures 4.4A and 4.4B). This suggests P.g may not trigger the intracellular degradation 
pathway to recycle desmosome molecules, but rather possess with a direct proteolytic activity. 
To confirm this, we co-cultured Pefabloc SC (serine protease inhibitor), Cathepsin B inhibitor 
(cysteine protease inhibitor), and Leupeptin (inhibitors for both) with P.g in the anaerobic 
chamber for 1h prior to bacterial challenges to HGEPs. In Figure 4.5C, both Leupeptin and 
Cathepsin B inhibitors restored PKP2 to an extent that mimicked the endogenous expression, but 
only partially restored DSG1 degradations. This may due to the fact that DSG1 is the 
extracellular component of the desmosome, which is more subjected to proteolytic activities. At 
the same time, Pefabloc SC did not restore any of these molecules degradation by P.g, suggesting 
that the degradation was due to cysteine proteases not serine proteases.  
Overall PKP2 DNA methylation is increased by bacterial challenges 
Emerging evidence has shown that DNA methylation is one mechanism regulating genes that 
are important to periodontal disease. The in vitro model can help revealing this mechanism. In 
this session, we studied whether P.g or C.r challenges altered the overall PKP2 DNA methylation 
in short period of time. P.g at MOI of 10 and 50 and C.r at MOI of 100 slightly increased PKP2 
DNA methylation (Figure 4.5A and 4.5B).  
Specific PKP2 CpG DNA methylation is not altered in periodontitis gingival biopsies 
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We have observed a hypermethylation pattern for PKP2 in response to P.g and C.r. 
Additionally, down-regulation of PKP2 mRNA in periodontitis gingival biopsies suggested a 
potential association with DNA hypermethylation of PKP2. Therefore, we tested for methylation 
patterns of specific CpG sites. For these five positions, periodontitis biopsies exhibited a trend of 
DNA hypermethylation pattern, but no differences reached the statistical significance (Figure 
4.5C). We further plotted the mRNA fold induction to the percentage of DNA methylation for 
each sample at position 2 and did not see a significant association (Figure 4.5D).    
Calcium switch results in co-localizations of PKP2 and DSG1  
Calcium levels affect cadherin proteins, but whether PKP2 is affected by calcium is unknown. 
The culture medium used to maintain HGEPs in this study contains low calcium levels (0.7uM). 
In this session, we aimed to study whether high calcium conditions affected PKP2 expression or 
interfered with bacterial challenges. After the overnight calcium switch, PKP2 presented a 
punctated staining pattern and co-localized with DSG1 at the cell adjunctions (Figure 4.6A). 
High Ca2+ increased DSG1 and DSC2, but not PKP2 protein. After P.g challenges, DSG1 and 
DSC2 proteins decreased in both low and high Ca2+ conditions. At MOI of 50, P.g degraded 
PKP2 in low Ca2+, but not in high Ca2+ (Figure 4.6B). When increasing MOI to 100, P.g 
degraded PKP2 in high Ca2+ as well (data not shown). These results suggest that calcium may 
strengthen desmosome junctions.  
PKP2 deficiency potentiates cell proliferation, spreading, and permeability 
Among the five shRNA constructs we screened, three constructs (sh1, sh2, sh4) were able to 
knock down PKP2 expression in HEGPs without interfering with β-actin expression. This was 
confirmed in HGEPs at 3 individual experiments. In one representative experiment (Figure 4.7A), 
sh1, sh2, and sh4 cells had reduced PKP2 proteins than scramble RNA control. We then seeded 
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2x104 HGEPs with normal or deficient PKP2 to 96 well plates and let them stay for 2 days 
before the start of the MTS assay. At 0h, 1d and 3d, MTS assay was performed. Compared to the 
scramble control, all three knocked down cells displayed significantly inhibited cell proliferation 
(Figure 4.7B). Cells with intact PKP2 tend to attach and spread better than those with deficient 
PKP2 (Figure 4.7C). We initially seeded shRNA and scramble RNA HGEPs into fibronectin-
treated transwell inserts and planned to apply FITC-dextran to test for cell barrier activity. 
However, we noticed that knocked down cells attached poorly to transwell inserts (data not 
shown), which provided another piece of evidence showing the impaired barrier in lack of PKP2. 
To compensate for this, we utilized P.g to decrease PKP2 in HGEPs in the transwell system. P.g 
treated HGEPs were more permeable to FITC-dextran in a dosage dependent manner, while heat-
killed P.g did not alter barrier activity (Figure 4.7D).  
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Discussion 
This study unravels an innovative role of PKP2 in periodontal disease. Our data strongly 
suggest the association between impaired functions of epithelial PKP2 and periodontal disease. 
Gingival biopsies from periodontitis subjects have decreased epithelial PKP2 mRNA expression 
(Figure 4.2). Abe D et al had similar findings showing that desmosome molecules DSG1 and 
DSC1 mRNA were down-regulated in gingival biopsies from periodontitis compared to those of 
healthy subjects (Abe et al., 2011). For decades, studies have found that major intercellular 
junctions are affected in periodontitis. For instance, gingival biopsies from periodontal disease 
subjects have aberrant staining patterns for tight junctions proteins, including occludin, claudin-4 
and 15, ZO-1 and 2, and JAM-A (Choi et al., 2014; Ye et al., 2014). Several groups have reported 
that E-cadherin is reduced in periodontitis gingival biopsies than healthy controls (Arun et al., 
2010; Loo et al., 2010; Nagarakanti et al., 2007). Connexin 26 and 43 are reduced in the 
pathological lining epithelium of periodontal pockets, indicating the alterations of gap junctions 
(Ye et al., 2000).  
 In order to delineate how PKP2 expression is regulated, we co-cultured gingival epithelial 
cells with P.g and other bacteria. PKP2 protein is reduced while mRNA is induced (Figure 4.3A 
and B). This discrepancy can be attributed to several reasons, including mRNA instability, 
inhibition of protein translation, or protein degradation. P.g are known to produce proteases to 
facilitate periodontium destructions (Grenier and La, 2011). Heat-killed P.g have no effect on 
PKP2, suggesting that protein products of P.g may affect PKP2 protein. Proteases are proved to 
be one of the products (Figure 4.3A). On the other hand, C.r do not regulate PKP2 or DSG1 
expression, suggesting the specificity of P.g on desmosome degradation (Figure 4.3E). P.g 
invade and spread among cells, therefore intracellular degradation mechanism may also lead to 
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desmosome degradation. Two major intracellular degradation pathways have been described in 
the literature. One is autophagy or lysosomal degradation, which delivers structural proteins to 
lysosome to degrade. The other is proteasome degradation, in which target proteins get 
ubiquitinated and transported to proteasome to be degraded. Inhibitors targeting these two 
pathways fail to prevent PKP2 or DSG1 degradation driven by P.g, eliminating the possible 
regulatory mechanisms of proteasome or autophagy (Figure 4.4A and 4.4B). These findings 
allow us to infer that P.g may degrade PKP2 and DSG1 by proteases directly. Indeed, cysteine 
proteases inhibitors prevent PKP2 degradation while serine proteases inhibitors fail to exert 
similar functions (Figure 4.4C). DSG1 degradation is partially prevented by cysteine proteases 
inhibitors. It is likely due to the fact that DSG1 is an extracellular component, which is subjected 
to proteases cleavages. Cysteine proteinases of P.g exist in the form of gingipains and the strain 
A7436 used in this study contains functional gingipains (Genco et al., 1998).  
Periodontal disease is a multifactorial disease that is controlled by many mechanisms. 
Several groups including us have reported that DNA methylation is involved in regulating key 
genes in periodontal disease (Andia et al., 2010; Zhang et al., 2013). Structural molecule like 
TLR2 is also a target for DNA methylation (Benakanakere et al., 2015). In accordance with 
decreased PKP2 mRNA, five CpG sites of PKP2 DNA methylation levels are slightly increased, 
but the differences are not statistically significant (Figure 4.5C).  Additionally, short-term 
exposures (24h) to P.g and C.r result in increased overall DNA methylation of PKP2 gene, 
suggesting that bacteria could alter DNA methylation machinery. However, whether long-term 
exposures of bacteria can continue altering DNA methylation or rather brings it to a homeostatic 
stage is still unknown. More in-depth studies are needed to discover the DNA methylation 
mechanism in PKP2 regulation.  
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Cadherin proteins like DSG and DSC are calcium-dependent. As expected, high Ca2+ 
increases DSG1 and DSC2 in gingival epithelial cells. PKP2 becomes punctated and co-localizes 
with DSG1 at cell junctions under high Ca2+, even though the total amount stays the same 
(Figure 4.6). These data suggest that calcium enhances desmosome junctions in vitro. P.g 
degrade PKP2 in low Ca2+, but not in high Ca2+ when MOI is at 50 (Figure 4.6A). P.g degrade 
DSG1 and DSC2 more potently in low Ca2+ (Figure 4.6B).  Low calcium allows us to observe 
apparent PKP2 degradation by P.g, thus is primarily used in experiments.  
The final part of this study focuses on studying the altered cell physiology after PKP2 is 
knocked down by shRNA. Three PKP2 knock down cells all demonstrate inhibited proliferation 
and cell attaching abilities, even the knocked down efficiency is only moderate (Figure 4.7A-C). 
PKP2 knocked down HGEPs fail to form a monolayer on transwell inserts, which indicates that 
lack of PKP2 is associated with impaired barrier functions (data not shown). Viable P.g impair 
cell barrier in a dosage dependent manner (Figure 4.7D). This evidence indirectly proves that 
lack of PKP2 is associated with impaired barrier functions.   
In summary, PKP2 expression is suppressed in gingival epithelial cells, which is associated with 
periodontal disease. P.g cysteine proteases selectively degrade PKP2 in the cell culture system. 
These data suggest that PKP2 may play an important role in maintaining epithelial integrity and 
play an important protective role in the etiopathogenesis of periodontal disease. 
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Table 4.1 Oligonucleotides used for bisulfite specific PCR and pyrosequencing  
CpG sites (*) Details Sequences 
-509, -518 Forward 5'- GAGTTTTTTTTTTAGGGAAGGT-3' 
-522, -553 Reverse 5'-biotin- CCCAAAACTACCATAAAACC-3' 
-567 Sequencer 5'- GTTTTTTTTTTAGGGAAG-3’ 
 
*CpG sites indicate nucleotides position in relation to transcription start. “-” indicates upstream 
of transcription start site. 
 
 
 
 
 
 
 
Table 4.2 Bisulfite specific PCR conditions for CpG containing amplicon 
    45 Cycles   
Amplicon 
Pre-
denaturation 
Denaturation Annealing Elongation Elongation 
°C, Time °C, Time °C, Time °C, Time °C, Time 
P1-P5 94, 15mins 94, 0.5mins 
54, 
0.5mins 
72, 
0.5mins 
72, 10mins 
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Table 4.3 Subjects demographic and clinical parameters  
  Healthy (N=11) Gingivitis (N=10) Periodontitis (N=10) P  
Age  39.5±3.8 34.0±3.2 49.6±3.2 0.01 
Female  9 5 6 0.3 
Caucasian  9 6 6 0.3 
Probing Depth 2.2±0.3 2.0±0.2 5.2±0.6 <0.0001 
Attachment Loss 1.1±0.2 1.2±0.1 4.4±0.5 <0.0001 
Values are presented in mean ± standard error or n. 
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Table 4.4 Short hairpin RNA targeted sequences  
ID Target Sequence 
sh1 CAACGTCACTGGATGCCTAAG 
sh2 TACTGACCTTCTCATTGAAAC 
sh3 CAGAGGAACCATTGCAGATTA 
sh4 AGGGACATTAATCCAATAAAT 
sh5 GTCTTTGTTATTAGGGCTTAT 
scramble CCTAAGGTTAAGTCGCCCTCGCTCGAGCGAGGGCGACTTAACCTTAGG 
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Figure 4.1 Genomic sequence of PKP2 promoter fragment. Sequence ranging from -572bp to 
+13bp relative to transcription start site (TSS) before bisulfite modification is presented. This 
promoter fragment upstream of TSS contains five investigated CpG dinucleotides that are 
marked with “*” and in bold. Their position in relation to TSS is also indicated above. Sites for 
potential transcriptional factor binding are underlined.  
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Figure 4.2 Epithelial PKP2 mRNA transcription is decreased in gingival biopsies from chronic 
periodontitis. A) Gingival biopsies from periodontitis subjects have significantly reduced PKP2 
mRNA compared to healthy and gingivitis biopsies. * indicates P<0.05; ** indicates P<0.01; NS 
is not significant. B) KRT5 mRNA is not significantly regulated between three conditions (NS). 
C. The fold change ratio of PKP2/KRT5 is significantly lower in chronic periodontitis biopsies 
(P<0.05).   
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Figure 4.3 PKP2 protein is degraded by viable P. gingivalis. A) After 24h of bacterial challenge, 
PKP2 protein is decreased by live P.g (MOI:50) but not heat-killed P.g. DSG1 protein decreases 
in response to P.g (all 3 MOIs). B) PKP2 mRNA increases in response to live P.g (MOI:50) not 
heat-killed P.g (* indicates P<0.05). C) PKP2 and DSG1 proteins are degraded in a time-
dependent manner. D) LPS from E. coli, P.g W83, and P.g A7436 (100ng/ml) do not affect 
PKP2 and DSG1 protein expression but TNF-α (10ng/ml) seems to increase protein expression. 
E). PKP2 and DSG1 proteins are not affected by C.recuts. Densitometric measurements were 
shown to the right of each immunoblot. Data are representatives of at least three independent 
experiments.  
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Figure 4.4 Degradation of PKP2 protein depends on cysteine proteases. A) The addition of the 
proteasome inhibitor MG132 does not prevent PKP2 and DSG1 degradation. B) The addition of 
lysosome inhibitor NH4Cl does not prevent PKP2 and DSG1 degradation. C) P.g were co-
cultured with different protease inhibitors for 1h anaerobically at 37C before treating HGEPs. 
Cysteine proteases inhibitors (Leupeptin and Cathepsin B inhibitor) greatly attenuate PKP2 
degradation by viable P.g. Both inhibitors partially restore DSG1 degradation by viable P.g.  
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Figure 4.5 PKP2 DNA methylation is associated with periodontal disease. A) and B) HGEPs 
display a global DNA hypermethylation pattern for PKP2 gene in response to P.g and C.r 
stimulation at 24h. C) The methylation percentage in periodontitis biopsies has an increased 
trend compared to healthy biopsies without meeting statistical significance. D) The PKP2 
mRNA of each biopsy sample is plotted against its methylation level at position 2. Regression 
analysis indicates that the transcriptional level of PKP2 is not significantly related to the 
methylation level at position 2.    
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Figure 4.6 PKP2 and DSG1 co-localize under high calcium condition. A) Fluorescent staining 
for PKP2 shows a punctated pattern under high calcium and forms co-localization with DSG1 at 
the cell adjunctions. B) High calcium increases cadherin molecules DSG1 and DSC2 proteins, 
but not affects the total amount of PKP2. P.g decrease PKP2 protein in low calcium but not in 
high calcium. DSG1 and DSC2 proteins are degraded by P.g in both high and low calcium 
conditions, but more potent degradations occur in low calcium. 
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Figure 4.7 Lack of PKP2 is associated with disrupted HGEPs homeostasis and impaired barrier 
functions. A) PKP2 is knocked down in sh1, 2, and 4. B) PKP2 deficiency inhibits HGEPs cell 
proliferation. C) PKP2 deficiency impairs cell attaching after 1h of seeding on fibronectin-coated 
dishes. D) P.g treated HGEPs have impaired cell barriers in a dosage dependent manner.   
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CHAPTER 5: DISCUSSION AND FUTURE DIRECTIONS 
 
Periodontal disease is a multifactorial disease that is regulated by complex etiopathogenesis 
mechanisms. In this study, we covered many aspects of periodontal disease from both cellular 
and tissue changes. Gingival epithelium provides an early line of defense against bacteria in the 
gingival sulcus, while gingival connective tissue fibroblast plays an integral role in tissue 
remodeling and host responses. On the other hand, gingival tissues need to maintain glucose 
homeostasis to survive and act.  
 Genetic risk burdens are also of great significance in periodontal disease. Over the years, 
many candidate genes have been identified that either predispose or protect subjects from 
developing periodontal diseases. These genes include but not limited to IL-1, IL-6, Fc gamma 
receptor, TNF-α, human vitamin D receptor, MMP-1, TLRs, COX-2, and C-reactive protein 
genes (Laine et al., 2012; Zhang et al., 2011). Mixed results are reported and extents of risks 
conferred by genetic differences are still under debate. It has been widely accepted that genetic 
risks of periodontitis may depend on a mixed pool of genes. To search for more candidate genes 
for periodontal disease, we conducted a genome-wide association study and have generated 
many interesting findings. Many new candidate genes have been found to be associated with 
severities of periodontitis (Divaris et al., 2013). We also have unpublished data suggesting that 
polymorphisms of human genes are associated with bacterial colonization. PKP2 gene is one of 
those genes. 5 SNPs variants (rs6488099, rs4931044, rs2389107, rs7962334, rs7299220) of 
PKP2 gene are significantly associated with the highest colonization of P. gingivalis among 909 
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subjects. In chapter 4, we have found that PKP2 expression is decreased in periodontitis gingival 
biopsies and P.gingivalis degradation is a potential driven force. Therefore, we further generate a 
hypothesis that hosts with differential PKP2 SNPs variants respond differently to P. gingivalis, 
which could predispose them to periodontal disease.  
For the future directions, we can acquire primary gingival epithelial cells from gingival 
explants of periodontitis and healthy subjects from designated genetic backgrounds. After 
genotyping each individual’s PKP2 SNPs, we will evaluate gingival epithelial cells for cell 
proliferation, attaching and spreading, and barrier activity. As demonstrated in Figure 4.7, we 
have already established a system that allows us to use different experimental approaches to test 
for potential roles of PKP2 SNPs variants. Similarly, hosts with differential PKP2 DNA 
methylation patterns may respond differently to P.gingivalis or other periodontal pathogens. In 
human gingival epithelial cells, TLR2 DNA hypermethylation is associated with dampened 
immune responses to P. gingivalis (Benakanakere et al., 2015). Although we did not capture a 
significant hypermethylation pattern of PKP2 gene in gingival biopsies, we did observe an 
elevation of overall methylation after a short term of bacterial challenges. For the future study, 
we can group gingival epithelial cells based on their methylation pattern and examine potential 
high responders or low responders. Additionally, a long-term bacterial culture system should be 
established to investigate the alteration of DNA methylation machinery affected by periodontal 
pathogens.  
PKP2 exerts multiple functions beyond being a desmosomal structural protein. PKP2 induces 
the phosphorylation of epidermal growth factor receptor (EGFR) to promote cell proliferation 
(Arimoto et al., 2014; Kazlauskas, 2014). Deficient PKP2 in keratinocytes leads to delayed 
migration through altered focal adhesion (Koetsier et al., 2014). An additional study has shown 
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that PKP2 directly interacts with β-catenin to potentiate TCF/LEF1-mediated transcription of 
target genes (Chen et al., 2002). PKP2 also associates with RNA polymerase III in the nucleus 
(Mertens et al., 2001). Since pol III regulates tRNA, rRNA 5S, and some small RNAs, PKP2 
may present post-translational functions as well.  
We have data showing that PKP2 is also potently expressed in gingival fibroblast, where 
DSG1 is lacking. Therefore, PKP2 may present multiple roles in periodontal disease, which is 
another direction to pursue. 
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